{"pair_id":"AIMed.d146.s1235.p0","sentence":"To determine the role of each of these receptors in ps IL-7 pe driven proliferation, ps IL-7R pe expression and proliferative capacity were monitored during mitogenic stimulation.","label":0}
{"pair_id":"AIMed.d157.s1329.p0","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, ps protein kinase C pe (ps PKC pe), binds AKAP79 at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p1","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, ps protein kinase C pe (PKC), binds ps AKAP79 pe at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p2","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, ps protein kinase C pe (PKC), binds AKAP79 at a site distinct from those bound by ps PKA pe or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p3","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, ps protein kinase C pe (PKC), binds AKAP79 at a site distinct from those bound by PKA or ps CaN pe.","label":0}
{"pair_id":"AIMed.d157.s1329.p4","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (ps PKC pe), binds ps AKAP79 pe at a site distinct from those bound by PKA or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p5","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (ps PKC pe), binds AKAP79 at a site distinct from those bound by ps PKA pe or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p6","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (ps PKC pe), binds AKAP79 at a site distinct from those bound by PKA or ps CaN pe.","label":0}
{"pair_id":"AIMed.d157.s1329.p7","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds ps AKAP79 pe at a site distinct from those bound by ps PKA pe or CaN.","label":0}
{"pair_id":"AIMed.d157.s1329.p8","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds ps AKAP79 pe at a site distinct from those bound by PKA or ps CaN pe.","label":0}
{"pair_id":"AIMed.d157.s1329.p9","sentence":"Deletion analysis and binding studies demonstrate that a third enzyme, protein kinase C (PKC), binds AKAP79 at a site distinct from those bound by ps PKA pe or ps CaN pe.","label":0}
{"pair_id":"BioInfer.d214.s1.p0","sentence":"Our data strongly support the view that the mobile form of ps actin pe in slow transport is soluble and that a substantial amount of this actin may travel as a complex with ps actin depolymerizing factor pe, cofilin, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p1","sentence":"Our data strongly support the view that the mobile form of ps actin pe in slow transport is soluble and that a substantial amount of this ps actin pe may travel as a complex with actin depolymerizing factor, cofilin, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p2","sentence":"Our data strongly support the view that the mobile form of ps actin pe in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, ps cofilin pe, and profilin.","label":0}
{"pair_id":"BioInfer.d214.s1.p3","sentence":"Our data strongly support the view that the mobile form of ps actin pe in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, cofilin, and ps profilin pe.","label":0}
{"pair_id":"BioInfer.d214.s1.p4","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this ps actin pe may travel as a complex with ps actin depolymerizing factor pe, cofilin, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p5","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with ps actin depolymerizing factor pe, ps cofilin pe, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p6","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with ps actin depolymerizing factor pe, cofilin, and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d214.s1.p7","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this ps actin pe may travel as a complex with actin depolymerizing factor, ps cofilin pe, and profilin.","label":1}
{"pair_id":"BioInfer.d214.s1.p8","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this ps actin pe may travel as a complex with actin depolymerizing factor, cofilin, and ps profilin pe.","label":1}
{"pair_id":"BioInfer.d214.s1.p9","sentence":"Our data strongly support the view that the mobile form of actin in slow transport is soluble and that a substantial amount of this actin may travel as a complex with actin depolymerizing factor, ps cofilin pe, and ps profilin pe.","label":1}
{"pair_id":"AIMed.d158.s1337.p0","sentence":"However, expression of the death domain of ps RIP pe Induces apoptosis, but potently inhibits ps NF-kappa B pe activation by TNF.","label":0}
{"pair_id":"BioInfer.d396.s0.p0","sentence":"It reduced the rate of ps actin pe polymerization as reported in the cases of ps profilins pe from other organisms.","label":0}
{"pair_id":"BioInfer.d181.s0.p0","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors ps p21 pe and ps p27 pe increased, whereas expression of cyclin D1 decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p1","sentence":"During apoptotic process induced by the agents, expression of ps cyclin-dependent kinase inhibitors pe ps p21 pe and p27 increased, whereas expression of cyclin D1 decreased.","label":1}
{"pair_id":"BioInfer.d181.s0.p2","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors ps p21 pe and p27 increased, whereas expression of ps cyclin D1 pe decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p3","sentence":"During apoptotic process induced by the agents, expression of ps cyclin-dependent kinase inhibitors pe p21 and ps p27 pe increased, whereas expression of cyclin D1 decreased.","label":1}
{"pair_id":"BioInfer.d181.s0.p4","sentence":"During apoptotic process induced by the agents, expression of cyclin-dependent kinase inhibitors p21 and ps p27 pe increased, whereas expression of ps cyclin D1 pe decreased.","label":0}
{"pair_id":"BioInfer.d181.s0.p5","sentence":"During apoptotic process induced by the agents, expression of ps cyclin-dependent kinase inhibitors pe p21 and p27 increased, whereas expression of ps cyclin D1 pe decreased.","label":0}
{"pair_id":"AIMed.d16.s137.p0","sentence":"Expressions of ps TH pe, ps AADC pe and GCH were detected by Western blot analysis.","label":0}
{"pair_id":"AIMed.d16.s137.p1","sentence":"Expressions of ps TH pe, AADC and ps GCH pe were detected by Western blot analysis.","label":0}
{"pair_id":"AIMed.d16.s137.p2","sentence":"Expressions of TH, ps AADC pe and ps GCH pe were detected by Western blot analysis.","label":0}
{"pair_id":"BioInfer.d652.s0.p0","sentence":"The N-terminal ps talin pe polypeptide eventually disrupted ps actin pe stress fibres whereas the C-terminal polypeptide was without effect.","label":1}
{"pair_id":"BioInfer.d350.s0.p0","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the ps cyclin dependent kinase inhibitor pe p27, which blocks the activating effects of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d350.s0.p1","sentence":"In order to help explain the apparent beneficial effects of ps cyclin D1 pe over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the ps cyclin dependent kinase inhibitor pe p27, which blocks the activating effects of cyclin D1.","label":0}
{"pair_id":"BioInfer.d350.s0.p2","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the ps cyclin dependent kinase inhibitor pe ps p27 pe, which blocks the activating effects of cyclin D1.","label":1}
{"pair_id":"BioInfer.d350.s0.p3","sentence":"In order to help explain the apparent beneficial effects of ps cyclin D1 pe over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor p27, which blocks the activating effects of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d350.s0.p4","sentence":"In order to help explain the apparent beneficial effects of cyclin D1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor ps p27 pe, which blocks the activating effects of ps cyclin D1 pe.","label":0}
{"pair_id":"BioInfer.d350.s0.p5","sentence":"In order to help explain the apparent beneficial effects of ps cyclin D1 pe over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the cyclin dependent kinase inhibitor ps p27 pe, which blocks the activating effects of cyclin D1.","label":0}
{"pair_id":"AIMed.d185.s1576.p0","sentence":"In contrast, tyrosine-phosphorylated peptides containing Tyr374 or Tyr396 did not interact with ps Stat3 pe or block ps Stat3 pe activation.","label":0}
{"pair_id":"AIMed.d103.s871.p0","sentence":"We show that ps hTAFII28 pe interacts with ps hTAFII18 pe both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with TBP.","label":1}
{"pair_id":"AIMed.d103.s871.p1","sentence":"We show that ps hTAFII28 pe interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, ps hTAFII28 pe also interacts directly with TBP.","label":0}
{"pair_id":"AIMed.d103.s871.p2","sentence":"We show that ps hTAFII28 pe interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with ps TBP pe.","label":0}
{"pair_id":"AIMed.d103.s871.p3","sentence":"We show that hTAFII28 interacts with ps hTAFII18 pe both in vitro and intracellularly; in contrast to its Drosophila homologue, ps hTAFII28 pe also interacts directly with TBP.","label":0}
{"pair_id":"AIMed.d103.s871.p4","sentence":"We show that hTAFII28 interacts with ps hTAFII18 pe both in vitro and intracellularly; in contrast to its Drosophila homologue, hTAFII28 also interacts directly with ps TBP pe.","label":0}
{"pair_id":"AIMed.d103.s871.p5","sentence":"We show that hTAFII28 interacts with hTAFII18 both in vitro and intracellularly; in contrast to its Drosophila homologue, ps hTAFII28 pe also interacts directly with ps TBP pe.","label":1}
{"pair_id":"AIMed.d120.s1013.p0","sentence":"Specific binding of the transglutaminase, ps platelet factor XIII pe, to ps HSP27 pe.","label":1}
{"pair_id":"BioInfer.d254.s0.p0","sentence":"Here, we show that the x-ray sensitivity of rad55 and ps rad57 pe mutant strains is suppressible by overexpression of ps RAD51 pe or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p1","sentence":"Here, we show that the x-ray sensitivity of ps rad55 pe and ps rad57 pe mutant strains is suppressible by overexpression of RAD51 or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p2","sentence":"Here, we show that the x-ray sensitivity of rad55 and ps rad57 pe mutant strains is suppressible by overexpression of RAD51 or ps RAD52 pe.","label":0}
{"pair_id":"BioInfer.d254.s0.p3","sentence":"Here, we show that the x-ray sensitivity of ps rad55 pe and rad57 mutant strains is suppressible by overexpression of ps RAD51 pe or RAD52.","label":0}
{"pair_id":"BioInfer.d254.s0.p4","sentence":"Here, we show that the x-ray sensitivity of rad55 and rad57 mutant strains is suppressible by overexpression of ps RAD51 pe or ps RAD52 pe.","label":0}
{"pair_id":"BioInfer.d254.s0.p5","sentence":"Here, we show that the x-ray sensitivity of ps rad55 pe and rad57 mutant strains is suppressible by overexpression of RAD51 or ps RAD52 pe.","label":0}
{"pair_id":"AIMed.d27.s229.p0","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as ps p16 pe and ps p21 pe and regulators of apoptosis such as p53 and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p1","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as ps p16 pe and p21 and regulators of apoptosis such as ps p53 pe and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p2","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as ps p16 pe and p21 and regulators of apoptosis such as p53 and members of the ps bcl-2 pe family.","label":0}
{"pair_id":"AIMed.d27.s229.p3","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and ps p21 pe and regulators of apoptosis such as ps p53 pe and members of the bcl-2 family.","label":0}
{"pair_id":"AIMed.d27.s229.p4","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and ps p21 pe and regulators of apoptosis such as p53 and members of the ps bcl-2 pe family.","label":0}
{"pair_id":"AIMed.d27.s229.p5","sentence":"Based on the experiences of all the authors, we emphasized cell cycle inhibitors such as p16 and p21 and regulators of apoptosis such as ps p53 pe and members of the ps bcl-2 pe family.","label":0}
{"pair_id":"AIMed.d61.s532.p0","sentence":"An expression plasmid encoding the human 75-kDa ps tumor necrosis factor (TNF) type 2 receptor pe (ps TNF-R2 pe) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p1","sentence":"An expression plasmid encoding the human 75-kDa ps tumor necrosis factor (TNF) type 2 receptor pe (TNF-R2) was constructed and used to generate a stable human cell line (293\/ps TNF-R2 pe) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p2","sentence":"An expression plasmid encoding the human 75-kDa ps tumor necrosis factor (TNF) type 2 receptor pe (TNF-R2) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing ps TNF-R2 pe.","label":0}
{"pair_id":"AIMed.d61.s532.p3","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (ps TNF-R2 pe) was constructed and used to generate a stable human cell line (293\/ps TNF-R2 pe) overexpressing TNF-R2.","label":0}
{"pair_id":"AIMed.d61.s532.p4","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (ps TNF-R2 pe) was constructed and used to generate a stable human cell line (293\/TNF-R2) overexpressing ps TNF-R2 pe.","label":0}
{"pair_id":"AIMed.d61.s532.p5","sentence":"An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293\/ps TNF-R2 pe) overexpressing ps TNF-R2 pe.","label":0}
{"pair_id":"AIMed.d190.s1618.p0","sentence":"Moreover we found that, upon ps SCF pe stimulation, the ps Grb2 pe\/c-Cbl complex recruits Shc, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p1","sentence":"Moreover we found that, upon ps SCF pe stimulation, the Grb2\/ps c-Cbl pe complex recruits Shc, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p2","sentence":"Moreover we found that, upon ps SCF pe stimulation, the Grb2\/c-Cbl complex recruits ps Shc pe, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p3","sentence":"Moreover we found that, upon ps SCF pe stimulation, the Grb2\/c-Cbl complex recruits Shc, probably via ps Grb2 pe.","label":0}
{"pair_id":"AIMed.d190.s1618.p4","sentence":"Moreover we found that, upon SCF stimulation, the ps Grb2 pe\/ps c-Cbl pe complex recruits Shc, probably via Grb2.","label":1}
{"pair_id":"AIMed.d190.s1618.p5","sentence":"Moreover we found that, upon SCF stimulation, the ps Grb2 pe\/c-Cbl complex recruits ps Shc pe, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p6","sentence":"Moreover we found that, upon SCF stimulation, the ps Grb2 pe\/c-Cbl complex recruits Shc, probably via ps Grb2 pe.","label":0}
{"pair_id":"AIMed.d190.s1618.p7","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/ps c-Cbl pe complex recruits ps Shc pe, probably via Grb2.","label":0}
{"pair_id":"AIMed.d190.s1618.p8","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/ps c-Cbl pe complex recruits Shc, probably via ps Grb2 pe.","label":0}
{"pair_id":"AIMed.d190.s1618.p9","sentence":"Moreover we found that, upon SCF stimulation, the Grb2\/c-Cbl complex recruits ps Shc pe, probably via ps Grb2 pe.","label":1}
{"pair_id":"BioInfer.d263.s1.p0","sentence":"In contrast, overexpression of the profilin gene, ps PFY1 pe, encoding an ps actin-binding protein pe, leads to no very obvious phenotype.","label":1}
{"pair_id":"BioInfer.d263.s1.p1","sentence":"In contrast, overexpression of the ps profilin pe gene, PFY1, encoding an ps actin-binding protein pe, leads to no very obvious phenotype.","label":1}
{"pair_id":"BioInfer.d263.s1.p2","sentence":"In contrast, overexpression of the ps profilin pe gene, ps PFY1 pe, encoding an actin-binding protein, leads to no very obvious phenotype.","label":0}
{"pair_id":"AIMed.d25.s204.p0","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p1","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p2","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, ps alpha-1-antitrypsin pe (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p3","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (ps alpha1AT pe), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p4","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors ps C3 pe and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p5","sentence":"The objective of this study was to measure the concentrations of ps tumor necrosis factor-alpha pe (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p6","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p7","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, ps alpha-1-antitrypsin pe (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p8","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (ps alpha1AT pe), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p9","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors ps C3 pe and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p10","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (ps TNFalpha pe) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p11","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, ps alpha-1-antitrypsin pe (alpha1AT), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p12","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, alpha-1-antitrypsin (ps alpha1AT pe), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p13","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, alpha-1-antitrypsin (alpha1AT), and complement factors ps C3 pe and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p14","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether ps TNFalpha pe, alpha-1-antitrypsin (alpha1AT), and complement factors C3 and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p15","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, ps alpha-1-antitrypsin pe (ps alpha1AT pe), and complement factors C3 and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p16","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, ps alpha-1-antitrypsin pe (alpha1AT), and complement factors ps C3 pe and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p17","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, ps alpha-1-antitrypsin pe (alpha1AT), and complement factors C3 and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p18","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (ps alpha1AT pe), and complement factors ps C3 pe and C4 can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p19","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (ps alpha1AT pe), and complement factors C3 and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"AIMed.d25.s204.p20","sentence":"The objective of this study was to measure the concentrations of tumor necrosis factor-alpha (TNFalpha) in pleural and peritoneal effusions of different causes and to verify whether TNFalpha, alpha-1-antitrypsin (alpha1AT), and complement factors ps C3 pe and ps C4 pe can be used in the differential diagnosis of serous effusion.","label":0}
{"pair_id":"BioInfer.d465.s1.p0","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and UL9, are necessary for the localization of ps ICP8 pe (ps UL29 pe) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p1","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and ps UL9 pe, are necessary for the localization of ps ICP8 pe (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p2","sentence":"We observed that four replication proteins, UL5, UL8 ps UL52 pe, and UL9, are necessary for the localization of ps ICP8 pe (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p3","sentence":"We observed that four replication proteins, UL5, ps UL8 pe UL52, and UL9, are necessary for the localization of ps ICP8 pe (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p4","sentence":"We observed that four replication proteins, ps UL5 pe, UL8 UL52, and UL9, are necessary for the localization of ps ICP8 pe (UL29) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p5","sentence":"We observed that four replication proteins, UL5, UL8 UL52, and ps UL9 pe, are necessary for the localization of ICP8 (ps UL29 pe) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p6","sentence":"We observed that four replication proteins, UL5, UL8 ps UL52 pe, and UL9, are necessary for the localization of ICP8 (ps UL29 pe) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p7","sentence":"We observed that four replication proteins, UL5, ps UL8 pe UL52, and UL9, are necessary for the localization of ICP8 (ps UL29 pe) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p8","sentence":"We observed that four replication proteins, ps UL5 pe, UL8 UL52, and UL9, are necessary for the localization of ICP8 (ps UL29 pe) to prereplicative sites natural infection conditions.","label":1}
{"pair_id":"BioInfer.d465.s1.p9","sentence":"We observed that four replication proteins, UL5, UL8 ps UL52 pe, and ps UL9 pe, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p10","sentence":"We observed that four replication proteins, UL5, ps UL8 pe UL52, and ps UL9 pe, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p11","sentence":"We observed that four replication proteins, ps UL5 pe, UL8 UL52, and ps UL9 pe, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p12","sentence":"We observed that four replication proteins, UL5, ps UL8 pe ps UL52 pe, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p13","sentence":"We observed that four replication proteins, ps UL5 pe, UL8 ps UL52 pe, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"BioInfer.d465.s1.p14","sentence":"We observed that four replication proteins, ps UL5 pe, ps UL8 pe UL52, and UL9, are necessary for the localization of ICP8 (UL29) to prereplicative sites natural infection conditions.","label":0}
{"pair_id":"AIMed.d15.s131.p0","sentence":"ps Interferon-gamma pe, ps IL-2 pe and IL-10 levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d15.s131.p1","sentence":"ps Interferon-gamma pe, IL-2 and ps IL-10 pe levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d15.s131.p2","sentence":"Interferon-gamma, ps IL-2 pe and ps IL-10 pe levels were statistically greater in patients.","label":0}
{"pair_id":"AIMed.d16.s136.p0","sentence":"METHODS: The genes for dopamine synthetic enzymes, ps tyrosine hydroxylase pe (ps TH pe), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p1","sentence":"METHODS: The genes for dopamine synthetic enzymes, ps tyrosine hydroxylase pe (TH), ps aromatic L-amino acid decarboxylase pe (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p2","sentence":"METHODS: The genes for dopamine synthetic enzymes, ps tyrosine hydroxylase pe (TH), aromatic L-amino acid decarboxylase (ps AADC pe), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p3","sentence":"METHODS: The genes for dopamine synthetic enzymes, ps tyrosine hydroxylase pe (TH), aromatic L-amino acid decarboxylase (AADC), and ps GTP cyclohydrolase I pe (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p4","sentence":"METHODS: The genes for dopamine synthetic enzymes, ps tyrosine hydroxylase pe (TH), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (ps GCH pe, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p5","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (ps TH pe), ps aromatic L-amino acid decarboxylase pe (AADC), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p6","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (ps TH pe), aromatic L-amino acid decarboxylase (ps AADC pe), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p7","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (ps TH pe), aromatic L-amino acid decarboxylase (AADC), and ps GTP cyclohydrolase I pe (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p8","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (ps TH pe), aromatic L-amino acid decarboxylase (AADC), and GTP cyclohydrolase I (ps GCH pe, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p9","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), ps aromatic L-amino acid decarboxylase pe (ps AADC pe), and GTP cyclohydrolase I (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p10","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), ps aromatic L-amino acid decarboxylase pe (AADC), and ps GTP cyclohydrolase I pe (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p11","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), ps aromatic L-amino acid decarboxylase pe (AADC), and GTP cyclohydrolase I (ps GCH pe, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p12","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (ps AADC pe), and ps GTP cyclohydrolase I pe (GCH, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p13","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (ps AADC pe), and GTP cyclohydrolase I (ps GCH pe, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"AIMed.d16.s136.p14","sentence":"METHODS: The genes for dopamine synthetic enzymes, tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC), and ps GTP cyclohydrolase I pe (ps GCH pe, an enzyme critical for tetrahydrobiopterin synthesis) were contransduced into 293 cells with separate AAV vectors.","label":0}
{"pair_id":"BioInfer.d43.s0.p0","sentence":"Although co-localization of ps glucokinase pe with ps actin pe filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, islet glucokinase was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":1}
{"pair_id":"BioInfer.d43.s0.p1","sentence":"Although co-localization of glucokinase with ps actin pe filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, ps islet glucokinase pe was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":0}
{"pair_id":"BioInfer.d43.s0.p2","sentence":"Although co-localization of ps glucokinase pe with actin filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, ps islet glucokinase pe was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.","label":0}
{"pair_id":"BioInfer.d279.s1.p0","sentence":"In cultured cells, cofilin, as well as ps ADF pe, translocates from the cytoplasm into the nucleus together with ps actin pe and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":1}
{"pair_id":"BioInfer.d279.s1.p1","sentence":"In cultured cells, ps cofilin pe, as well as ps ADF pe, translocates from the cytoplasm into the nucleus together with actin and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":0}
{"pair_id":"BioInfer.d279.s1.p2","sentence":"In cultured cells, ps cofilin pe, as well as ADF, translocates from the cytoplasm into the nucleus together with ps actin pe and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.","label":1}
{"pair_id":"AIMed.d57.s504.p0","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (ps hsp90 pe) has been used here to form complexes between the ps pp60src pe tyrosine kinase and hsp90.","label":0}
{"pair_id":"AIMed.d57.s504.p1","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (ps hsp90 pe) has been used here to form complexes between the pp60src tyrosine kinase and ps hsp90 pe.","label":0}
{"pair_id":"AIMed.d57.s504.p2","sentence":"A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the ps pp60src pe tyrosine kinase and ps hsp90 pe.","label":1}
{"pair_id":"AIMed.d138.s1170.p0","sentence":"Furthermore, the 60-kilodalton subunit of ps SF3a pe is related to the yeast splicing protein ps PRP9 pe.","label":0}
{"pair_id":"AIMed.d14.s118.p0","sentence":"Correlations between ps GFAp pe and ps NFL pe in CSF as markers for astrogliosis and neurodegeneration, and clinical and biological data were investigated.","label":0}
{"pair_id":"BioInfer.d333.s0.p0","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive ps sarcomeric actin pe and sarcomeric myosin heavy chain (ps SMHC pe) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p1","sentence":"In enriched cell lines and in a pure myocyte cell strain, ps EGF pe inhibited increases in immunoreactive ps sarcomeric actin pe and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.","label":1}
{"pair_id":"BioInfer.d333.s0.p2","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive ps sarcomeric actin pe and ps sarcomeric myosin heavy chain pe (SMHC) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p3","sentence":"In enriched cell lines and in a pure myocyte cell strain, ps EGF pe inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (ps SMHC pe) normally seen after serum withdrawal.","label":1}
{"pair_id":"BioInfer.d333.s0.p4","sentence":"In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and ps sarcomeric myosin heavy chain pe (ps SMHC pe) normally seen after serum withdrawal.","label":0}
{"pair_id":"BioInfer.d333.s0.p5","sentence":"In enriched cell lines and in a pure myocyte cell strain, ps EGF pe inhibited increases in immunoreactive sarcomeric actin and ps sarcomeric myosin heavy chain pe (SMHC) normally seen after serum withdrawal.","label":1}
{"pair_id":"AIMed.d48.s422.p0","sentence":"We report chemotaxis and competitive binding studies that show ps LEC pe binds to and activates ps CCR1 pe and CCR8 transfected HEK-293 cells.","label":1}
{"pair_id":"AIMed.d48.s422.p1","sentence":"We report chemotaxis and competitive binding studies that show ps LEC pe binds to and activates CCR1 and ps CCR8 pe transfected HEK-293 cells.","label":1}
{"pair_id":"AIMed.d48.s422.p2","sentence":"We report chemotaxis and competitive binding studies that show LEC binds to and activates ps CCR1 pe and ps CCR8 pe transfected HEK-293 cells.","label":0}
{"pair_id":"AIMed.d57.s505.p0","sentence":"Reticulocyte lysate forms complexes between ps hsp90 pe and a temperature-sensitive mutant of Rous sarcoma virus ps pp60v-src pe, which is normally present in cytosol virtually entirely in the multiprotein complex form.","label":1}
{"pair_id":"AIMed.d180.s1536.p0","sentence":"Surprisingly, the N-terminal third of ps GAP-43 pe alone bound ps CaM pe more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":1}
{"pair_id":"AIMed.d180.s1536.p1","sentence":"Surprisingly, the N-terminal third of ps GAP-43 pe alone bound CaM more strongly than did intact ps GAP-43 pe, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":0}
{"pair_id":"AIMed.d180.s1536.p2","sentence":"Surprisingly, the N-terminal third of ps GAP-43 pe alone bound CaM more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with ps CaM pe.","label":0}
{"pair_id":"AIMed.d180.s1536.p3","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound ps CaM pe more strongly than did intact ps GAP-43 pe, suggesting that the protein's C-terminus may play a role in modulating the interaction with CaM.","label":1}
{"pair_id":"AIMed.d180.s1536.p4","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound ps CaM pe more strongly than did intact GAP-43, suggesting that the protein's C-terminus may play a role in modulating the interaction with ps CaM pe.","label":0}
{"pair_id":"AIMed.d180.s1536.p5","sentence":"Surprisingly, the N-terminal third of GAP-43 alone bound CaM more strongly than did intact ps GAP-43 pe, suggesting that the protein's C-terminus may play a role in modulating the interaction with ps CaM pe.","label":0}
{"pair_id":"AIMed.d151.s1288.p0","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (ps TBP pe) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p1","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with ps PTF pe, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p2","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with PTF, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p3","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with PTF, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p4","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p5","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p6","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the ps TATA-binding protein pe (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p7","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with ps PTF pe, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p8","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with PTF, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p9","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with PTF, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p10","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p11","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p12","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (ps TBP pe) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p13","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with ps PTF pe, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p14","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with ps PTF pe, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p15","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with ps PTF pe, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p16","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with ps PTF pe, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p17","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with ps PTF pe, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p18","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a ps PTF pe-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p19","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p20","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p21","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a ps PTF pe-related complex (SNAPc) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p22","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p23","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p24","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (ps SNAPc pe) containing substoichiometric levels of TBP and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p25","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (ps SNAPc43 pe) identical in sequence to the PTF gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p26","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of ps TBP pe and a component (SNAPc43) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d151.s1288.p27","sentence":"Immunoprecipitation assays also show a weak substoichiometric association of the TATA-binding protein (TBP) with PTF, consistent with the previous report of a PTF-related complex (SNAPc) containing substoichiometric levels of TBP and a component (ps SNAPc43 pe) identical in sequence to the ps PTF pe gamma reported here.","label":0}
{"pair_id":"AIMed.d119.s1007.p0","sentence":"ps CREB pe is activated through phosphorylation by ps protein kinase A pe (PKA), but precisely how phosphorylation stimulates CREB function is unknown.","label":1}
{"pair_id":"AIMed.d119.s1007.p1","sentence":"ps CREB pe is activated through phosphorylation by protein kinase A (ps PKA pe), but precisely how phosphorylation stimulates CREB function is unknown.","label":1}
{"pair_id":"AIMed.d119.s1007.p2","sentence":"ps CREB pe is activated through phosphorylation by protein kinase A (PKA), but precisely how phosphorylation stimulates ps CREB pe function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p3","sentence":"CREB is activated through phosphorylation by ps protein kinase A pe (ps PKA pe), but precisely how phosphorylation stimulates CREB function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p4","sentence":"CREB is activated through phosphorylation by ps protein kinase A pe (PKA), but precisely how phosphorylation stimulates ps CREB pe function is unknown.","label":0}
{"pair_id":"AIMed.d119.s1007.p5","sentence":"CREB is activated through phosphorylation by protein kinase A (ps PKA pe), but precisely how phosphorylation stimulates ps CREB pe function is unknown.","label":0}
{"pair_id":"BioInfer.d358.s0.p0","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein ps talin pe by ps calpain pe.","label":1}
{"pair_id":"BioInfer.d358.s0.p1","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of ps actin pe or cleavage of linking protein ps talin pe by calpain.","label":0}
{"pair_id":"BioInfer.d358.s0.p2","sentence":"ps Integrin pe binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein ps talin pe by calpain.","label":0}
{"pair_id":"BioInfer.d358.s0.p3","sentence":"Integrin binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of ps actin pe or cleavage of linking protein talin by ps calpain pe.","label":0}
{"pair_id":"BioInfer.d358.s0.p4","sentence":"ps Integrin pe binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of actin or cleavage of linking protein talin by ps calpain pe.","label":0}
{"pair_id":"BioInfer.d358.s0.p5","sentence":"ps Integrin pe binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of ps actin pe or cleavage of linking protein talin by calpain.","label":0}
{"pair_id":"AIMed.d71.s603.p0","sentence":"The proto-oncogene ps c-jun pe is a component of the ps AP-1 pe transcription factor family involved in the mediation of nuclear events elicited by extracellular stimuli.","label":0}
{"pair_id":"BioInfer.d169.s0.p0","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) ps profilin pe exhibited two different modes of interaction with ps actin pe, like mammalian profilin.","label":1}
{"pair_id":"BioInfer.d169.s0.p1","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) profilin exhibited two different modes of interaction with ps actin pe, like mammalian ps profilin pe.","label":1}
{"pair_id":"BioInfer.d169.s0.p2","sentence":"Depending on the nature of the divalent cation, recombinant plant (birch) ps profilin pe exhibited two different modes of interaction with actin, like mammalian ps profilin pe.","label":0}
{"pair_id":"AIMed.d209.s1812.p0","sentence":"This ps RIN1 pe sequence shows preferential binding to the ps ABL-SH3 pe domain in vitro.","label":1}
{"pair_id":"BioInfer.d183.s1.p0","sentence":"The distribution of ps actin pe filaments is altered by ps profilin pe overexpression.","label":1}
{"pair_id":"BioInfer.d418.s0.p0","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, ps alpha-catenin pe and ps gamma-catenin pe were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p1","sentence":"Membranous staining and concomitant cytoplasmic localization of ps E-cadherin pe, alpha-catenin and ps gamma-catenin pe were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p2","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and ps gamma-catenin pe were seen in one case with abnormal ps beta-catenin pe immunoreactivity.","label":0}
{"pair_id":"BioInfer.d418.s0.p3","sentence":"Membranous staining and concomitant cytoplasmic localization of ps E-cadherin pe, ps alpha-catenin pe and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.","label":1}
{"pair_id":"BioInfer.d418.s0.p4","sentence":"Membranous staining and concomitant cytoplasmic localization of E-cadherin, ps alpha-catenin pe and gamma-catenin were seen in one case with abnormal ps beta-catenin pe immunoreactivity.","label":0}
{"pair_id":"BioInfer.d418.s0.p5","sentence":"Membranous staining and concomitant cytoplasmic localization of ps E-cadherin pe, alpha-catenin and gamma-catenin were seen in one case with abnormal ps beta-catenin pe immunoreactivity.","label":0}
{"pair_id":"AIMed.d87.s740.p0","sentence":"This activation with ps p85 pe and ps IGF-1R pe beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p1","sentence":"This activation with ps p85 pe and ps IGF-1R beta pe was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p2","sentence":"This activation with ps p85 pe and IGF-1R beta was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p3","sentence":"This activation with ps p85 pe and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R pe beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p4","sentence":"This activation with ps p85 pe and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R beta pe (delta C-43).","label":1}
{"pair_id":"AIMed.d87.s740.p5","sentence":"This activation with ps p85 pe and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (ps delta C-4 pe3).","label":0}
{"pair_id":"AIMed.d87.s740.p6","sentence":"This activation with p85 and ps IGF-1R peps IGF-1R beta pe was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p7","sentence":"This activation with p85 and ps IGF-1R pe beta was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p8","sentence":"This activation with p85 and ps IGF-1R pe beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R pe beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p9","sentence":"This activation with p85 and ps IGF-1R pe beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R beta pe (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p10","sentence":"This activation with p85 and ps IGF-1R pe beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (ps delta C-4 pe3).","label":0}
{"pair_id":"AIMed.d87.s740.p11","sentence":"This activation with p85 and ps IGF-1R beta pe was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for IGF-1R beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p12","sentence":"This activation with p85 and ps IGF-1R beta pe was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R pe beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p13","sentence":"This activation with p85 and ps IGF-1R beta pe was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R beta pe (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p14","sentence":"This activation with p85 and ps IGF-1R beta pe was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for IGF-1R beta (ps delta C-4 pe3).","label":0}
{"pair_id":"AIMed.d87.s740.p15","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for ps IGF-1R pe beta (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p16","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for ps IGF-1R beta pe (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p17","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to ps IR beta pe and was somewhat increased (2-fold) for IGF-1R beta (ps delta C-4 pe3).","label":0}
{"pair_id":"AIMed.d87.s740.p18","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R peps IGF-1R beta pe (delta C-43).","label":0}
{"pair_id":"AIMed.d87.s740.p19","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R pe beta (ps delta C-4 pe3).","label":0}
{"pair_id":"AIMed.d87.s740.p20","sentence":"This activation with p85 and IGF-1R beta was 4-fold less as compared to IR beta and was somewhat increased (2-fold) for ps IGF-1R beta pe (ps delta C-4 pe3).","label":0}
{"pair_id":"BioInfer.d467.s0.p0","sentence":"On the other hand, we have recently proposed the importance of ps cofilin pe, an ps actin pe-binding phosphoprotein, in phagocyte functions through dephosphorylation and translocation to the plasma membrane regions.","label":1}
{"pair_id":"BioInfer.d232.s0.p0","sentence":"Genetic dissection of Drosophila myofibril formation: effects of ps actin pe and ps myosin heavy chain pe null alleles.","label":0}
{"pair_id":"AIMed.d96.s813.p0","sentence":"In vitro binding studies demonstrated that the intracellular segment of ps PTPmu pe binds directly to the intracellular domain of ps E-cadherin pe, but not to alpha- or beta-catenin.","label":1}
{"pair_id":"AIMed.d96.s813.p1","sentence":"In vitro binding studies demonstrated that the intracellular segment of ps PTPmu pe binds directly to the intracellular domain of E-cadherin, but not to alpha- or ps beta-catenin pe.","label":0}
{"pair_id":"AIMed.d96.s813.p2","sentence":"In vitro binding studies demonstrated that the intracellular segment of PTPmu binds directly to the intracellular domain of ps E-cadherin pe, but not to alpha- or ps beta-catenin pe.","label":0}
{"pair_id":"AIMed.d176.s1486.p0","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p1","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p2","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p3","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p4","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p5","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p6","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p7","sentence":"In the present study we observe that a monoclonal antibody specific for ps p60 pe can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p8","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p9","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p10","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p11","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p12","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p13","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p14","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature ps PR pe complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p15","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p16","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p17","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p18","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p19","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p20","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing ps heat shock protein 90 pe (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p21","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p22","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p23","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p24","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p25","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (ps hsp90 pe), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p26","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p27","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p28","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p29","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), ps p23 pe, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p30","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing ps hsp70 pe and Hip (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p31","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p32","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early ps PR pe complexes containing hsp70 and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p33","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and ps Hip pe (p48).","label":0}
{"pair_id":"AIMed.d176.s1486.p34","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing ps hsp70 pe and Hip (ps p48 pe).","label":0}
{"pair_id":"AIMed.d176.s1486.p35","sentence":"In the present study we observe that a monoclonal antibody specific for p60 can, on the one hand, inhibit formation of mature PR complexes containing heat shock protein 90 (hsp90), p23, and immunophilins and, on the other, enhance recovery of early PR complexes containing hsp70 and ps Hip pe (ps p48 pe).","label":0}
{"pair_id":"BioInfer.d293.s0.p0","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for ps alpha-smooth muscle actin pe and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for ps desmin pe and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p1","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for ps desmin pe and ps nonmuscle myosin heavy chain II-B pe.","label":0}
{"pair_id":"BioInfer.d293.s0.p2","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and ps smooth muscle myosin heavy chain pe and a weak to moderate reactivity of a lesser number of cells for ps desmin pe and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p3","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for ps alpha-smooth muscle actin pe and smooth muscle myosin heavy chain and a weak to moderate reactivity of a lesser number of cells for desmin and ps nonmuscle myosin heavy chain II-B pe.","label":0}
{"pair_id":"BioInfer.d293.s0.p4","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for ps alpha-smooth muscle actin pe and ps smooth muscle myosin heavy chain pe and a weak to moderate reactivity of a lesser number of cells for desmin and nonmuscle myosin heavy chain II-B.","label":0}
{"pair_id":"BioInfer.d293.s0.p5","sentence":"Immunohistochemical studies showed a strong reactivity of most LAM cells for alpha-smooth muscle actin and ps smooth muscle myosin heavy chain pe and a weak to moderate reactivity of a lesser number of cells for desmin and ps nonmuscle myosin heavy chain II-B pe.","label":0}
{"pair_id":"BioInfer.d61.s0.p0","sentence":"Analysis of various truncated alpha-catenin molecules revealed that amino-terminal residues 48-163 are able to bind to ps beta-catenin pe and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d61.s0.p1","sentence":"Analysis of various truncated ps alpha-catenin pe molecules revealed that amino-terminal residues 48-163 are able to bind to beta-catenin and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d61.s0.p2","sentence":"Analysis of various truncated ps alpha-catenin pe molecules revealed that amino-terminal residues 48-163 are able to bind to ps beta-catenin pe and plakoglobin.","label":1}
{"pair_id":"BioInfer.d33.s2.p0","sentence":"MATERIALS AND METHODS: We used an ps avidin pe-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, ps beta-catenin pe, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p1","sentence":"MATERIALS AND METHODS: We used an ps avidin pe-biotin immunoperoxidase technique to examine the cellular localization of ps alpha-catenin pe, beta-catenin, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p2","sentence":"MATERIALS AND METHODS: We used an ps avidin pe-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, gamma-catenin and ps E-cadherin pe in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p3","sentence":"MATERIALS AND METHODS: We used an ps avidin pe-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, ps gamma-catenin pe and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p4","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of ps alpha-catenin pe, ps beta-catenin pe, gamma-catenin and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p5","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, ps beta-catenin pe, gamma-catenin and ps E-cadherin pe in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p6","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, ps beta-catenin pe, ps gamma-catenin pe and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p7","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of ps alpha-catenin pe, beta-catenin, gamma-catenin and ps E-cadherin pe in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p8","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of ps alpha-catenin pe, beta-catenin, ps gamma-catenin pe and E-cadherin in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"BioInfer.d33.s2.p9","sentence":"MATERIALS AND METHODS: We used an avidin-biotin immunoperoxidase technique to examine the cellular localization of alpha-catenin, beta-catenin, ps gamma-catenin pe and ps E-cadherin pe in 68 TCC and 14 normal bladder biopsies.","label":0}
{"pair_id":"AIMed.d0.s5.p0","sentence":"Cytokines measurements during ps IFN-alpha pe treatment showed a trend to decreasing levels of ps IL-4 pe at 4, 12, and 24 weeks.","label":0}
{"pair_id":"AIMed.d222.s1931.p0","sentence":"The screen identified interactions involving ps c-Cbl pe and two 14-3-3 isoforms, ps cytokeratin 18 pe, human unconventional myosin IC, and a recently identified SH3 domain containing protein, SH3 P17.","label":1}
{"pair_id":"AIMed.d222.s1931.p1","sentence":"The screen identified interactions involving ps c-Cbl pe and two 14-3-3 isoforms, cytokeratin 18, human unconventional myosin IC, and a recently identified SH3 domain containing protein, ps SH3 P17 pe.","label":1}
{"pair_id":"AIMed.d222.s1931.p2","sentence":"The screen identified interactions involving c-Cbl and two 14-3-3 isoforms, ps cytokeratin 18 pe, human unconventional myosin IC, and a recently identified SH3 domain containing protein, ps SH3 P17 pe.","label":0}
{"pair_id":"AIMed.d121.s1031.p0","sentence":"These mutations have no impact on the ability of the ps p53 pe protein to bind to a ps p53 pe-specific DNA element.","label":0}
{"pair_id":"AIMed.d182.s1545.p0","sentence":"Structure of the ps MDM2 pe oncoprotein bound to the ps p53 pe tumor suppressor transactivation domain.","label":1}
{"pair_id":"BioInfer.d792.s0.p0","sentence":"ps VASP pe, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding ps profilin pe, an actin-regulatory protein that stimulates actin filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p1","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding ps profilin pe, an ps actin pe-regulatory protein that stimulates actin filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p2","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding ps profilin pe, an actin-regulatory protein that stimulates ps actin pe filament assembly.","label":1}
{"pair_id":"BioInfer.d792.s0.p3","sentence":"ps VASP pe, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an ps actin pe-regulatory protein that stimulates actin filament assembly.","label":0}
{"pair_id":"BioInfer.d792.s0.p4","sentence":"ps VASP pe, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an actin-regulatory protein that stimulates ps actin pe filament assembly.","label":0}
{"pair_id":"BioInfer.d792.s0.p5","sentence":"VASP, in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding profilin, an ps actin pe-regulatory protein that stimulates ps actin pe filament assembly.","label":0}
{"pair_id":"BioInfer.d288.s2.p0","sentence":"The NH2-terminal 16kD of ps Abp1p pe, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast ps cofilin pe.","label":1}
{"pair_id":"BioInfer.d288.s2.p1","sentence":"The NH2-terminal 16kD of ps Abp1p pe, a 65-kD yeast protein identified by its ability to bind to ps actin pe filaments, is 23% identical to yeast cofilin.","label":1}
{"pair_id":"BioInfer.d288.s2.p2","sentence":"The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to ps actin pe filaments, is 23% identical to yeast ps cofilin pe.","label":0}
{"pair_id":"BioInfer.d497.s1.p0","sentence":"The ps actin-binding protein pe ps profilin pe binds to PIP2 and inhibits its hydrolysis by phospholipase C.","label":1}
{"pair_id":"BioInfer.d497.s1.p1","sentence":"The ps actin-binding protein pe profilin binds to PIP2 and inhibits its hydrolysis by ps phospholipase C pe.","label":0}
{"pair_id":"BioInfer.d497.s1.p2","sentence":"The actin-binding protein ps profilin pe binds to PIP2 and inhibits its hydrolysis by ps phospholipase C pe.","label":0}
{"pair_id":"AIMed.d190.s1612.p0","sentence":"In the present study we evaluated tyrosine phosphorylation of ps c-Cbl pe and the interaction of the ps Grb2 pe\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p1","sentence":"In the present study we evaluated tyrosine phosphorylation of ps c-Cbl pe and the interaction of the Grb2\/ps c-Cbl pe complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p2","sentence":"In the present study we evaluated tyrosine phosphorylation of ps c-Cbl pe and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (ps c-Mpl pe) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p3","sentence":"In the present study we evaluated tyrosine phosphorylation of ps c-Cbl pe and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (ps c-Kit pe) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p4","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the ps Grb2 pe\/ps c-Cbl pe complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":1}
{"pair_id":"AIMed.d190.s1612.p5","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the ps Grb2 pe\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (ps c-Mpl pe) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p6","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the ps Grb2 pe\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (ps c-Kit pe) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p7","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/ps c-Cbl pe complex with signaling proteins upon activation of non-tyrosine (ps c-Mpl pe) and tyrosine kinase (c-Kit) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p8","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/ps c-Cbl pe complex with signaling proteins upon activation of non-tyrosine (c-Mpl) and tyrosine kinase (ps c-Kit pe) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"AIMed.d190.s1612.p9","sentence":"In the present study we evaluated tyrosine phosphorylation of c-Cbl and the interaction of the Grb2\/c-Cbl complex with signaling proteins upon activation of non-tyrosine (ps c-Mpl pe) and tyrosine kinase (ps c-Kit pe) receptors leading to myeloid cell proliferation.","label":0}
{"pair_id":"BioInfer.d398.s1.p0","sentence":"The data suggest that profilin binding to ps actin pe weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the ps actin pe central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p1","sentence":"The data suggest that profilin binding to actin weakens nucleotide binding to ps actin pe by disrupting Mg(2+) coordination in the ps actin pe central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p2","sentence":"The data suggest that ps profilin pe binding to actin weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the ps actin pe central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p3","sentence":"The data suggest that profilin binding to ps actin pe weakens nucleotide binding to ps actin pe by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p4","sentence":"The data suggest that ps profilin pe binding to ps actin pe weakens nucleotide binding to actin by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d398.s1.p5","sentence":"The data suggest that ps profilin pe binding to actin weakens nucleotide binding to ps actin pe by disrupting Mg(2+) coordination in the actin central cleft.","label":1}
{"pair_id":"BioInfer.d3.s1.p0","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of utrophin, ps acetylcholine receptor pe, and ps acetylcholinesterase pe at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p1","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of ps utrophin pe, ps acetylcholine receptor pe, and acetylcholinesterase at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p2","sentence":"Thus, ps alpha-syntrophin pe has an important role in synapse formation and in the organization of utrophin, ps acetylcholine receptor pe, and acetylcholinesterase at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d3.s1.p3","sentence":"Thus, alpha-syntrophin has an important role in synapse formation and in the organization of ps utrophin pe, acetylcholine receptor, and ps acetylcholinesterase pe at the neuromuscular synapse.","label":0}
{"pair_id":"BioInfer.d3.s1.p4","sentence":"Thus, ps alpha-syntrophin pe has an important role in synapse formation and in the organization of utrophin, acetylcholine receptor, and ps acetylcholinesterase pe at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d3.s1.p5","sentence":"Thus, ps alpha-syntrophin pe has an important role in synapse formation and in the organization of ps utrophin pe, acetylcholine receptor, and acetylcholinesterase at the neuromuscular synapse.","label":1}
{"pair_id":"BioInfer.d65.s0.p0","sentence":"An oligomeric form of simian virus 40 ps large T-antigen pe is immunologically related to the cellular tumor antigen ps p53 pe.","label":1}
{"pair_id":"BioInfer.d117.s0.p0","sentence":"By 1 h the cells were well spread with straight ps actin pe bundles many of which ended at more central sites terminating on patches containing vinculin and ps talin pe; thus the cells assemble typical stress fibers but do not appear to polarize.","label":0}
{"pair_id":"BioInfer.d117.s0.p1","sentence":"By 1 h the cells were well spread with straight actin bundles many of which ended at more central sites terminating on patches containing ps vinculin pe and ps talin pe; thus the cells assemble typical stress fibers but do not appear to polarize.","label":1}
{"pair_id":"BioInfer.d117.s0.p2","sentence":"By 1 h the cells were well spread with straight ps actin pe bundles many of which ended at more central sites terminating on patches containing ps vinculin pe and talin; thus the cells assemble typical stress fibers but do not appear to polarize.","label":0}
{"pair_id":"BioInfer.d471.s0.p0","sentence":"Other than monomeric ps actin pe, no major ps profilin pe ligands are detected in crude extracts.","label":1}
{"pair_id":"BioInfer.d57.s0.p0","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the ps spleen actin pe (sple, ps splee pe) which appears to regulate the interaction with ps profilin pe.","label":1}
{"pair_id":"BioInfer.d57.s0.p1","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the ps spleen actin pe (ps sple pe, splee) which appears to regulate the interaction with ps profilin pe.","label":1}
{"pair_id":"BioInfer.d57.s0.p2","sentence":"Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the ps spleen actin peps spleen actin pe (ps sple pe, ps splee pe) which appears to regulate the interaction with profilin.","label":0}
{"pair_id":"AIMed.d32.s271.p0","sentence":"We used alanine substitution of ps EBP pe residues that contact ps EMP1 pe in the crystal structure to investigate the function of these residues in both EMP1 and EPO binding.","label":1}
{"pair_id":"AIMed.d32.s271.p1","sentence":"We used alanine substitution of ps EBP pe residues that contact EMP1 in the crystal structure to investigate the function of these residues in both ps EMP1 pe and EPO binding.","label":1}
{"pair_id":"AIMed.d32.s271.p2","sentence":"We used alanine substitution of ps EBP pe residues that contact EMP1 in the crystal structure to investigate the function of these residues in both EMP1 and ps EPO pe binding.","label":1}
{"pair_id":"AIMed.d32.s271.p3","sentence":"We used alanine substitution of EBP residues that contact ps EMP1 pe in the crystal structure to investigate the function of these residues in both ps EMP1 pe and EPO binding.","label":0}
{"pair_id":"AIMed.d32.s271.p4","sentence":"We used alanine substitution of EBP residues that contact ps EMP1 pe in the crystal structure to investigate the function of these residues in both EMP1 and ps EPO pe binding.","label":0}
{"pair_id":"AIMed.d32.s271.p5","sentence":"We used alanine substitution of EBP residues that contact EMP1 in the crystal structure to investigate the function of these residues in both ps EMP1 pe and ps EPO pe binding.","label":0}
{"pair_id":"BioInfer.d214.s2.p0","sentence":"We examined the axonal transport of ps actin pe and its monomer binding proteins, actin depolymerizing factor, cofilin, and ps profilin pe, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p1","sentence":"We examined the axonal transport of actin and its monomer binding proteins, ps actin depolymerizing factor pe, cofilin, and ps profilin pe, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"BioInfer.d214.s2.p2","sentence":"We examined the axonal transport of actin and its monomer binding proteins, actin depolymerizing factor, ps cofilin pe, and ps profilin pe, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"BioInfer.d214.s2.p3","sentence":"We examined the axonal transport of ps actin pe and its monomer binding proteins, ps actin depolymerizing factor pe, cofilin, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p4","sentence":"We examined the axonal transport of ps actin pe and its monomer binding proteins, actin depolymerizing factor, ps cofilin pe, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":1}
{"pair_id":"BioInfer.d214.s2.p5","sentence":"We examined the axonal transport of actin and its monomer binding proteins, ps actin depolymerizing factor pe, ps cofilin pe, and profilin, in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.","label":0}
{"pair_id":"AIMed.d207.s1793.p0","sentence":"In differentiating C2C12 cells, ps E2F pe complexes switch and DNA synthesis in response to serum are prevented when ps MyoD pe DNA binding activity and the cdks inhibitor MyoD downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p1","sentence":"In differentiating C2C12 cells, ps E2F pe complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor ps MyoD pe downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p2","sentence":"In differentiating C2C12 cells, ps E2F pe complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor MyoD downstream effector ps p21 pe are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p3","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when ps MyoD pe DNA binding activity and the cdks inhibitor ps MyoD pe downstream effector p21 are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p4","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when ps MyoD pe DNA binding activity and the cdks inhibitor MyoD downstream effector ps p21 pe are induced.","label":0}
{"pair_id":"AIMed.d207.s1793.p5","sentence":"In differentiating C2C12 cells, E2F complexes switch and DNA synthesis in response to serum are prevented when MyoD DNA binding activity and the cdks inhibitor ps MyoD pe downstream effector ps p21 pe are induced.","label":0}
{"pair_id":"AIMed.d183.s1558.p0","sentence":"In addition, ps JAK2 pe phosphorylated ps Raf-1 pe at sites different from those phosphorylated by pp60v-src.","label":1}
{"pair_id":"AIMed.d183.s1558.p1","sentence":"In addition, ps JAK2 pe phosphorylated Raf-1 at sites different from those phosphorylated by ps pp60v-src pe.","label":0}
{"pair_id":"AIMed.d183.s1558.p2","sentence":"In addition, JAK2 phosphorylated ps Raf-1 pe at sites different from those phosphorylated by ps pp60v-src pe.","label":1}
{"pair_id":"BioInfer.d650.s0.p0","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of ps actin pe to one that bound actin more strongly than wild-type ps profilin pe.","label":0}
{"pair_id":"BioInfer.d650.s0.p1","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of actin to one that bound ps actin pe more strongly than wild-type ps profilin pe.","label":1}
{"pair_id":"BioInfer.d650.s0.p2","sentence":"The mutants ranged in affinity, from those that only weakly affected polymerization of ps actin pe to one that bound ps actin pe more strongly than wild-type profilin.","label":0}
{"pair_id":"BioInfer.d104.s0.p0","sentence":"MSH3 appears to be more closely related to the mouse ps Rep-3 pe gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other ps mutS pe homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p1","sentence":"MSH3 appears to be more closely related to the mouse ps Rep-3 pe gene and other similar eukaryotic ps mutS pe homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p2","sentence":"ps MSH3 pe appears to be more closely related to the mouse ps Rep-3 pe gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p3","sentence":"MSH3 appears to be more closely related to the mouse ps Rep-3 pe gene and other similar eukaryotic mutS homologues than to the yeast gene ps MSH2 pe and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p4","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic ps mutS pe homologues than to the yeast gene MSH2 and other ps mutS pe homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p5","sentence":"ps MSH3 pe appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene MSH2 and other ps mutS pe homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p6","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene ps MSH2 pe and other ps mutS pe homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p7","sentence":"ps MSH3 pe appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic ps mutS pe homologues than to the yeast gene MSH2 and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"BioInfer.d104.s0.p8","sentence":"MSH3 appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic ps mutS pe homologues than to the yeast gene ps MSH2 pe and other mutS homologues that are involved in replication repair.","label":0}
{"pair_id":"BioInfer.d104.s0.p9","sentence":"ps MSH3 pe appears to be more closely related to the mouse Rep-3 gene and other similar eukaryotic mutS homologues than to the yeast gene ps MSH2 pe and other mutS homologues that are involved in replication repair.","label":1}
{"pair_id":"AIMed.d193.s1647.p0","sentence":"Further investigation indicated that the ps ITF-2b pe\/ps MyoD pe heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/HLH462.","label":1}
{"pair_id":"AIMed.d193.s1647.p1","sentence":"Further investigation indicated that the ps ITF-2b pe\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by ps Id3 pe\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1647.p2","sentence":"Further investigation indicated that the ps ITF-2b pe\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/ps HLH462 pe.","label":0}
{"pair_id":"AIMed.d193.s1647.p3","sentence":"Further investigation indicated that the ITF-2b\/ps MyoD pe heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by ps Id3 pe\/HLH462.","label":0}
{"pair_id":"AIMed.d193.s1647.p4","sentence":"Further investigation indicated that the ITF-2b\/ps MyoD pe heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by Id3\/ps HLH462 pe.","label":0}
{"pair_id":"AIMed.d193.s1647.p5","sentence":"Further investigation indicated that the ITF-2b\/MyoD heterodimer bound to its specific DNA binding site in vitro, and the DNA binding was effectively blocked by ps Id3 pe\/ps HLH462 pe.","label":0}
{"pair_id":"AIMed.d167.s1409.p0","sentence":"A ps GT155 pe mutant that was not glycosylated (AGGT155) did not associate with ps calnexin pe or CAP-60.","label":0}
{"pair_id":"AIMed.d167.s1409.p1","sentence":"A ps GT155 pe mutant that was not glycosylated (AGGT155) did not associate with calnexin or ps CAP-60 pe.","label":0}
{"pair_id":"AIMed.d167.s1409.p2","sentence":"A GT155 mutant that was not glycosylated (AGGT155) did not associate with ps calnexin pe or ps CAP-60 pe.","label":0}
{"pair_id":"BioInfer.d155.s0.p0","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of ps alpha-catenin pe binds beta-catenin and plakoglobin, and can form a structural complex with ps E-cadherin pe via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p1","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of ps alpha-catenin pe binds ps beta-catenin pe and plakoglobin, and can form a structural complex with E-cadherin via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p2","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of ps alpha-catenin pe binds beta-catenin and ps plakoglobin pe, and can form a structural complex with E-cadherin via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p3","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds ps beta-catenin pe and plakoglobin, and can form a structural complex with ps E-cadherin pe via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p4","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and ps plakoglobin pe, and can form a structural complex with ps E-cadherin pe via these interactions.","label":1}
{"pair_id":"BioInfer.d155.s0.p5","sentence":"Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds ps beta-catenin pe and ps plakoglobin pe, and can form a structural complex with E-cadherin via these interactions.","label":0}
{"pair_id":"AIMed.d150.s1281.p0","sentence":"These results demonstrate that ps Rb pe interacts specifically with a lineage-restricted ps Ets pe transcription factor.","label":0}
{"pair_id":"BioInfer.d627.s0.p0","sentence":"The influence of these ps collagens pe on cell morphology and the distribution pattern of actin, ps vimentin pe, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p1","sentence":"The influence of these ps collagens pe on cell morphology and the distribution pattern of ps actin pe, vimentin, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p2","sentence":"The influence of these ps collagens pe on cell morphology and the distribution pattern of actin, vimentin, talin, and ps vinculin pe was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p3","sentence":"The influence of these ps collagens pe on cell morphology and the distribution pattern of actin, vimentin, ps talin pe, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":1}
{"pair_id":"BioInfer.d627.s0.p4","sentence":"The influence of these collagens on cell morphology and the distribution pattern of ps actin pe, ps vimentin pe, talin, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p5","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, ps vimentin pe, talin, and ps vinculin pe was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p6","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, ps vimentin pe, ps talin pe, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p7","sentence":"The influence of these collagens on cell morphology and the distribution pattern of ps actin pe, vimentin, talin, and ps vinculin pe was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p8","sentence":"The influence of these collagens on cell morphology and the distribution pattern of ps actin pe, vimentin, ps talin pe, and vinculin was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d627.s0.p9","sentence":"The influence of these collagens on cell morphology and the distribution pattern of actin, vimentin, ps talin pe, and ps vinculin pe was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.","label":0}
{"pair_id":"BioInfer.d92.s0.p0","sentence":"Because ps beta-catenin pe is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the ps actin pe binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p1","sentence":"Because ps beta-catenin pe is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d92.s0.p2","sentence":"Because ps beta-catenin pe is known to interact with alpha-catenin, which binds to ps actin pe, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p3","sentence":"Because ps beta-catenin pe is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of ps E-cadherin pe and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p4","sentence":"Because ps beta-catenin pe is known to interact with ps alpha-catenin pe, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":1}
{"pair_id":"BioInfer.d92.s0.p5","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the ps actin pe binding site of ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d92.s0.p6","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to ps actin pe, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the ps actin pe binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p7","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of ps E-cadherin pe and the ps actin pe binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p8","sentence":"Because beta-catenin is known to interact with ps alpha-catenin pe, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the ps actin pe binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p9","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to ps actin pe, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d92.s0.p10","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to actin, we generated a fusion molecule consisting of the ectodomain of ps E-cadherin pe and the actin binding site of ps alpha-catenin pe.","label":1}
{"pair_id":"BioInfer.d92.s0.p11","sentence":"Because beta-catenin is known to interact with ps alpha-catenin pe, which binds to actin, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d92.s0.p12","sentence":"Because beta-catenin is known to interact with alpha-catenin, which binds to ps actin pe, we generated a fusion molecule consisting of the ectodomain of ps E-cadherin pe and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"BioInfer.d92.s0.p13","sentence":"Because beta-catenin is known to interact with ps alpha-catenin pe, which binds to ps actin pe, we generated a fusion molecule consisting of the ectodomain of E-cadherin and the actin binding site of alpha-catenin.","label":1}
{"pair_id":"BioInfer.d92.s0.p14","sentence":"Because beta-catenin is known to interact with ps alpha-catenin pe, which binds to actin, we generated a fusion molecule consisting of the ectodomain of ps E-cadherin pe and the actin binding site of alpha-catenin.","label":0}
{"pair_id":"AIMed.d144.s1221.p0","sentence":"Moreover, similar ps p110RB pe sequences are required for binding ps PP-1 alpha 2 pe and SV40 large T antigen.","label":1}
{"pair_id":"AIMed.d144.s1221.p1","sentence":"Moreover, similar ps p110RB pe sequences are required for binding PP-1 alpha 2 and ps SV40 large T antigen pe.","label":1}
{"pair_id":"AIMed.d144.s1221.p2","sentence":"Moreover, similar p110RB sequences are required for binding ps PP-1 alpha 2 pe and ps SV40 large T antigen pe.","label":0}
{"pair_id":"BioInfer.d361.s0.p0","sentence":"Interactions of ADF\/ps cofilin pe, ps Arp pe2\/ps A pe complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p1","sentence":"Interactions of ps ADF pe\/cofilin, ps Arp pe2\/ps A pe complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p2","sentence":"Interactions of ADF\/cofilin, ps Arp pe2\/ps A pe complex, capping protein and profilin in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p3","sentence":"Interactions of ADF\/cofilin, ps Arp pe2\/ps A pe complex, ps capping protein pe and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p4","sentence":"Interactions of ADF\/cofilin, ps Arp peps Arp2 pe\/ps A pe complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p5","sentence":"Interactions of ADF\/cofilin, ps Arp pe2\/ps A pe complex, capping protein and ps profilin pe in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p6","sentence":"Interactions of ps ADF pe\/ps cofilin pe, Arp2\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":0}
{"pair_id":"BioInfer.d361.s0.p7","sentence":"Interactions of ADF\/ps cofilin pe, Arp2\/A complex, capping protein and profilin in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p8","sentence":"Interactions of ADF\/ps cofilin pe, Arp2\/A complex, ps capping protein pe and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p9","sentence":"Interactions of ADF\/ps cofilin pe, ps Arp2 pe\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p10","sentence":"Interactions of ADF\/ps cofilin pe, Arp2\/A complex, capping protein and ps profilin pe in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p11","sentence":"Interactions of ps ADF pe\/cofilin, Arp2\/A complex, capping protein and profilin in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p12","sentence":"Interactions of ps ADF pe\/cofilin, Arp2\/A complex, ps capping protein pe and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p13","sentence":"Interactions of ps ADF pe\/cofilin, ps Arp2 pe\/A complex, capping protein and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p14","sentence":"Interactions of ps ADF pe\/cofilin, Arp2\/A complex, capping protein and ps profilin pe in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p15","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, ps capping protein pe and profilin in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p16","sentence":"Interactions of ADF\/cofilin, ps Arp2 pe\/A complex, capping protein and profilin in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p17","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, capping protein and ps profilin pe in remodeling of branched ps actin pe filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p18","sentence":"Interactions of ADF\/cofilin, ps Arp2 pe\/A complex, ps capping protein pe and profilin in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p19","sentence":"Interactions of ADF\/cofilin, Arp2\/A complex, ps capping protein pe and ps profilin pe in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d361.s0.p20","sentence":"Interactions of ADF\/cofilin, ps Arp2 pe\/A complex, capping protein and ps profilin pe in remodeling of branched actin filament networks.","label":1}
{"pair_id":"BioInfer.d7.s3.p0","sentence":"Mechanism of action of Acanthamoeba ps profilin pe: demonstration of ps actin pe species specificity and regulation by micromolar concentrations of MgCl2.","label":0}
{"pair_id":"BioInfer.d375.s0.p0","sentence":"In this model, ps profilin pe can bind both to ps actin pe monomers with a Kd of about 5 microM and to the barbed end of actin filaments with a Kd of about 50-100 microM.","label":1}
{"pair_id":"BioInfer.d375.s0.p1","sentence":"In this model, ps profilin pe can bind both to actin monomers with a Kd of about 5 microM and to the barbed end of ps actin pe filaments with a Kd of about 50-100 microM.","label":1}
{"pair_id":"BioInfer.d375.s0.p2","sentence":"In this model, profilin can bind both to ps actin pe monomers with a Kd of about 5 microM and to the barbed end of ps actin pe filaments with a Kd of about 50-100 microM.","label":0}
{"pair_id":"AIMed.d130.s1112.p0","sentence":"Cloning of the complete coding region for human ps protein phosphatase inhibitor 2 pe using the two hybrid system and expression of ps inhibitor 2 pe in E. coli.","label":0}
{"pair_id":"AIMed.d85.s723.p0","sentence":"The main ps p47nck pe region implicated in the association with ps p66WASP pe was found to be the carboxy-terminal SH3 domain.","label":1}
{"pair_id":"BioInfer.d105.s0.p0","sentence":"ps Neuropilin-1 pe is also expressed in endothelial cells and shown to bind vascular endothelial growth factor (ps VEGF pe), a potent regulator for vasculogenesis and angiogenesis.","label":1}
{"pair_id":"BioInfer.d105.s0.p1","sentence":"Neuropilin-1 is also expressed in endothelial cells and shown to bind ps vascular endothelial growth factor pe (ps VEGF pe), a potent regulator for vasculogenesis and angiogenesis.","label":0}
{"pair_id":"BioInfer.d105.s0.p2","sentence":"ps Neuropilin-1 pe is also expressed in endothelial cells and shown to bind ps vascular endothelial growth factor pe (VEGF), a potent regulator for vasculogenesis and angiogenesis.","label":1}
{"pair_id":"AIMed.d20.s168.p0","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules ps tumour necrosis factors (TNF) alpha pe and beta, ps transforming growth factors (TGF) beta1 pe and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p1","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules ps tumour necrosis factors (TNF) alpha pe and beta, transforming growth factors (TGF) beta1 and 2, ps interleukin (IL) 1 pe and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p2","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules ps tumour necrosis factors (TNF) alpha pe and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (ps IL 1ra pe), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p3","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules ps tumour necrosis factors (TNF) alpha pe and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), ps CD14 pe (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p4","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules ps tumour necrosis factors (TNF) alpha pe and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and ps platelet endothelial cell adhesion molecule (PECAM) 1 pe.","label":0}
{"pair_id":"AIMed.d20.s168.p5","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, ps transforming growth factors (TGF) beta1 pe and 2, ps interleukin (IL) 1 pe and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p6","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, ps transforming growth factors (TGF) beta1 pe and 2, interleukin (IL) 1 and its receptor antagonist (ps IL 1ra pe), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p7","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, ps transforming growth factors (TGF) beta1 pe and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), ps CD14 pe (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p8","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, ps transforming growth factors (TGF) beta1 pe and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and ps platelet endothelial cell adhesion molecule (PECAM) 1 pe.","label":0}
{"pair_id":"AIMed.d20.s168.p9","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, ps interleukin (IL) 1 pe and its receptor antagonist (ps IL 1ra pe), CD14 (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p10","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, ps interleukin (IL) 1 pe and its receptor antagonist (IL 1ra), ps CD14 pe (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p11","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, ps interleukin (IL) 1 pe and its receptor antagonist (IL 1ra), CD14 (the receptor for lipopolysaccharide), P and E selectins, and ps platelet endothelial cell adhesion molecule (PECAM) 1 pe.","label":0}
{"pair_id":"AIMed.d20.s168.p12","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (ps IL 1ra pe), ps CD14 pe (the receptor for lipopolysaccharide), P and E selectins, and platelet endothelial cell adhesion molecule (PECAM) 1.","label":0}
{"pair_id":"AIMed.d20.s168.p13","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (ps IL 1ra pe), CD14 (the receptor for lipopolysaccharide), P and E selectins, and ps platelet endothelial cell adhesion molecule (PECAM) 1 pe.","label":0}
{"pair_id":"AIMed.d20.s168.p14","sentence":"Accordingly, a number of population studies have explored the association of ischaemic heart disease with gene polymorphisms of the inflammatory molecules tumour necrosis factors (TNF) alpha and beta, transforming growth factors (TGF) beta1 and 2, interleukin (IL) 1 and its receptor antagonist (IL 1ra), ps CD14 pe (the receptor for lipopolysaccharide), P and E selectins, and ps platelet endothelial cell adhesion molecule (PECAM) 1 pe.","label":0}
{"pair_id":"AIMed.d205.s1776.p0","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of ps PI 3-kinase pe and ps pp120 pe to CD5.","label":0}
{"pair_id":"AIMed.d205.s1776.p1","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of ps PI 3-kinase pe and pp120 to ps CD5 pe.","label":1}
{"pair_id":"AIMed.d205.s1776.p2","sentence":"We conclude that stimulation of thymocytes with pervanadate induces the recruitment of PI 3-kinase and ps pp120 pe to ps CD5 pe.","label":1}
{"pair_id":"AIMed.d216.s1875.p0","sentence":"An arginine side chain (arginine-789) of ps GAP-334 pe is supplied into the active site of ps Ras pe to neutralize developing charges in the transition state.","label":0}
{"pair_id":"BioInfer.d44.s0.p0","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p1","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p2","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p3","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p4","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p5","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p6","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p7","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p8","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p9","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p10","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p11","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p12","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p13","sentence":"Although neither activation of ps BCK1 pe (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p14","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p15","sentence":"Although neither activation of ps BCK1 pe (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p16","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p17","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p18","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p19","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p20","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p21","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p22","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p23","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p24","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p25","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p26","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p27","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p28","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p29","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p30","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of ps MKK1 pe (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p31","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p32","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p33","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p34","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p35","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p36","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p37","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p38","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p39","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p40","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p41","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p42","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p43","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p44","sentence":"Although neither activation of BCK1 (MEKK) by the dominant ps BCK1-20 pe mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p45","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p46","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p47","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p48","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p49","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p50","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p51","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p52","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p53","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p54","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p55","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p56","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p57","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, ps HCS77 pe\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p58","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p59","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p60","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p61","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p62","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p63","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p64","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p65","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p66","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p67","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p68","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p69","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the ps Pkc1p pe pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p70","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p71","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p72","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p73","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p74","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p75","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p76","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p77","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p78","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p79","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p80","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/ps WSC1 pe\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p81","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p82","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p83","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p84","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p85","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p86","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p87","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p88","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p89","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p90","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and ps MID2 pe also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p91","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p92","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p93","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p94","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p95","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p96","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p97","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p98","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p99","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, ps RHO2 pe, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p100","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p101","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p102","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p103","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p104","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p105","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p106","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or ps MPK1 pe (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p107","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or ps MPK1 pe (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p108","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p109","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p110","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p111","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p112","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p113","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p114","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ps ROM2 pe, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p115","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p116","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p117","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed ps glc7-10 pe effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p118","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p119","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p120","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed ps glc7-10 pe effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p121","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":1}
{"pair_id":"BioInfer.d44.s0.p122","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p123","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p124","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p125","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a ps glc7-10 pe dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p126","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p127","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p128","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p129","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked ps PKC1 pe as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p130","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p131","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p132","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/ps SLG1 pe and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p133","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p134","sentence":"Although neither activation of BCK1 (ps MEKK pe) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"BioInfer.d44.s0.p135","sentence":"Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (ps MEK pe) or MPK1 (ps MAP kinase pe) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77\/WSC1\/SLG1 and MID2 also suppressed glc7-10 effectively.","label":0}
{"pair_id":"AIMed.d204.s1758.p0","sentence":"Wild-type ps MMP-1 pe, as well as the ps MMP-1 pe mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p1","sentence":"Wild-type ps MMP-1 pe, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-ps MMP-1 pe], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p2","sentence":"Wild-type ps MMP-1 pe, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with ps trypsin pe or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p3","sentence":"Wild-type MMP-1, as well as the ps MMP-1 pe mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-ps MMP-1 pe], exhibit enzymatic activity upon cleavage of the prodomain by treatment with trypsin or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p4","sentence":"Wild-type MMP-1, as well as the ps MMP-1 pe mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-MMP-1], exhibit enzymatic activity upon cleavage of the prodomain by treatment with ps trypsin pe or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d204.s1758.p5","sentence":"Wild-type MMP-1, as well as the MMP-1 mutant lacking the C-terminal hemopexin-like domain [des-(248-450)-ps MMP-1 pe], exhibit enzymatic activity upon cleavage of the prodomain by treatment with ps trypsin pe or 4-aminophenylmercuric acetate.","label":0}
{"pair_id":"AIMed.d176.s1490.p0","sentence":"Since ps hsp90 pe and ps hsp70 pe do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p1","sentence":"Since ps hsp90 pe and hsp70 do not readily associate on their own, it appears that ps p60 pe is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p2","sentence":"Since ps hsp90 pe and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an ps hsp90 pe-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p3","sentence":"Since ps hsp90 pe and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-ps p60 pe-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p4","sentence":"Since ps hsp90 pe and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-ps hsp70 pe complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p5","sentence":"Since hsp90 and ps hsp70 pe do not readily associate on their own, it appears that ps p60 pe is the central organizing component of an hsp90-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p6","sentence":"Since hsp90 and ps hsp70 pe do not readily associate on their own, it appears that p60 is the central organizing component of an ps hsp90 pe-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p7","sentence":"Since hsp90 and ps hsp70 pe do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-ps p60 pe-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p8","sentence":"Since hsp90 and ps hsp70 pe do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-p60-ps hsp70 pe complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p9","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that ps p60 pe is the central organizing component of an ps hsp90 pe-p60-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p10","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that ps p60 pe is the central organizing component of an hsp90-ps p60 pe-hsp70 complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p11","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that ps p60 pe is the central organizing component of an hsp90-p60-ps hsp70 pe complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p12","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an ps hsp90 pe-ps p60 pe-hsp70 complex.","label":1}
{"pair_id":"AIMed.d176.s1490.p13","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an ps hsp90 pe-p60-ps hsp70 pe complex.","label":0}
{"pair_id":"AIMed.d176.s1490.p14","sentence":"Since hsp90 and hsp70 do not readily associate on their own, it appears that p60 is the central organizing component of an hsp90-ps p60 pe-ps hsp70 pe complex.","label":0}
{"pair_id":"AIMed.d51.s455.p0","sentence":"Here we report the crystal structure of the ps FGFR2 pe ectodomain in a dimeric form that is induced by simultaneous binding to ps FGF1 pe and a heparin decasaccharide.","label":1}
{"pair_id":"BioInfer.d446.s0.p0","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p1","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p2","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p3","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p4","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p5","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p6","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p7","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p8","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p9","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p10","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p11","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p12","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, ps DDC2 pe MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p13","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p14","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p15","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p16","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p17","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p18","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p19","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p20","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p21","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p22","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p23","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p24","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, ps RAD24 pe, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p25","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p26","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p27","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p28","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p29","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p30","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p31","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p32","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p33","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p34","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p35","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and ps DUN1 pe increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p36","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p37","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p38","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p39","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p40","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p41","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p42","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p43","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p44","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p45","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in ps RAD9 pe, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p46","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p47","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p48","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p49","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p50","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p51","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p52","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p53","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p54","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, ps CHK1 pe, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p55","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p56","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p57","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p58","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p59","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p60","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p61","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p62","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, ps PDS1 pe, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p63","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p64","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p65","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p66","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p67","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p68","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p69","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, ps RAD17 pe, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p70","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p71","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p72","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p73","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p74","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p75","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, ps RAD53 pe, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p76","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p77","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p78","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p79","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p80","sentence":"Mutations in Saccharomyces cerevisiae RFC5, ps DPB11 pe, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p81","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p82","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p83","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p84","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, ps MEC1 pe, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p85","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p86","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p87","sentence":"Mutations in Saccharomyces cerevisiae ps RFC5 pe, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p88","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and MAD3 had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p89","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 ps MEC3 pe, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"BioInfer.d446.s0.p90","sentence":"Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, ps BUB3 pe, and ps MAD3 pe had little effect.","label":0}
{"pair_id":"AIMed.d174.s1471.p0","sentence":"The increased binding affinity of ps IL-6D pe appears to be due to its ability to cross-link two ps sIL-6R pe molecules on the biosensor surface.","label":1}
{"pair_id":"BioInfer.d68.s1.p0","sentence":"ps Green fluorescent protein pe-tagged ORC1 associated with chromatin throughout mitosis in living cells and co-localized with ps ORC4 pe in metaphase spreads.","label":0}
{"pair_id":"BioInfer.d68.s1.p1","sentence":"ps Green fluorescent protein pe-tagged ps ORC1 pe associated with chromatin throughout mitosis in living cells and co-localized with ORC4 in metaphase spreads.","label":1}
{"pair_id":"BioInfer.d68.s1.p2","sentence":"Green fluorescent protein-tagged ps ORC1 pe associated with chromatin throughout mitosis in living cells and co-localized with ps ORC4 pe in metaphase spreads.","label":1}
{"pair_id":"BioInfer.d321.s1.p0","sentence":"In this study, we immunohistochemically investigated the expression of ps beta-catenin pe as well as E-cadherin and ps alpha-catenin pe in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"BioInfer.d321.s1.p1","sentence":"In this study, we immunohistochemically investigated the expression of ps beta-catenin pe as well as ps E-cadherin pe and alpha-catenin in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"BioInfer.d321.s1.p2","sentence":"In this study, we immunohistochemically investigated the expression of beta-catenin as well as ps E-cadherin pe and ps alpha-catenin pe in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.","label":0}
{"pair_id":"AIMed.d131.s1122.p0","sentence":"Mouse ps IL-10 pe does not bind to ps hIL-10R pe, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p1","sentence":"Mouse ps IL-10 pe does not bind to hIL-10R, and ps hIL-10R pe-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p2","sentence":"Mouse ps IL-10 pe does not bind to hIL-10R, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1122.p3","sentence":"Mouse IL-10 does not bind to ps hIL-10R pe, and ps hIL-10R pe-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of IL-10.","label":0}
{"pair_id":"AIMed.d131.s1122.p4","sentence":"Mouse IL-10 does not bind to ps hIL-10R pe, and hIL-10R-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d131.s1122.p5","sentence":"Mouse IL-10 does not bind to hIL-10R, and ps hIL-10R pe-expressing Ba\/F3 cells do not respond to the mouse cytokine, observations consistent with the known species specificity of ps IL-10 pe.","label":0}
{"pair_id":"AIMed.d102.s859.p0","sentence":"The ps retinoblastoma pe-susceptibility gene product binds directly to the human ps TATA-binding protein pe-associated factor TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p1","sentence":"The ps retinoblastoma pe-susceptibility gene product binds directly to the human ps TATA-binding protein-associated factor pe TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p2","sentence":"The ps retinoblastoma pe-susceptibility gene product binds directly to the human TATA-binding protein-associated factor ps TAFII250 pe.","label":1}
{"pair_id":"AIMed.d102.s859.p3","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human ps TATA-binding protein peps TATA-binding protein-associated factor pe TAFII250.","label":0}
{"pair_id":"AIMed.d102.s859.p4","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human ps TATA-binding protein pe-associated factor ps TAFII250 pe.","label":0}
{"pair_id":"AIMed.d102.s859.p5","sentence":"The retinoblastoma-susceptibility gene product binds directly to the human ps TATA-binding protein-associated factor pe ps TAFII250 pe.","label":0}
{"pair_id":"AIMed.d166.s1394.p0","sentence":"Residues in human ps leukemia inhibitory factor pe (ps hLIF pe) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p1","sentence":"Residues in human ps leukemia inhibitory factor pe (hLIF) crucial for binding to both the human ps LIF receptor pe (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p2","sentence":"Residues in human ps leukemia inhibitory factor pe (hLIF) crucial for binding to both the human LIF receptor (R) and ps gp130 pe were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p3","sentence":"Residues in human ps leukemia inhibitory factor pe (hLIF) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of ps hLIF pe in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p4","sentence":"Residues in human leukemia inhibitory factor (ps hLIF pe) crucial for binding to both the human ps LIF receptor pe (R) and gp130 were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p5","sentence":"Residues in human leukemia inhibitory factor (ps hLIF pe) crucial for binding to both the human LIF receptor (R) and ps gp130 pe were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":1}
{"pair_id":"AIMed.d166.s1394.p6","sentence":"Residues in human leukemia inhibitory factor (ps hLIF pe) crucial for binding to both the human LIF receptor (R) and gp130 were identified by analysis of alanine scanning mutants of ps hLIF pe in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p7","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human ps LIF receptor pe (R) and ps gp130 pe were identified by analysis of alanine scanning mutants of hLIF in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p8","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human ps LIF receptor pe (R) and gp130 were identified by analysis of alanine scanning mutants of ps hLIF pe in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"AIMed.d166.s1394.p9","sentence":"Residues in human leukemia inhibitory factor (hLIF) crucial for binding to both the human LIF receptor (R) and ps gp130 pe were identified by analysis of alanine scanning mutants of ps hLIF pe in assays for both receptor binding and bioactivity.","label":0}
{"pair_id":"BioInfer.d397.s0.p0","sentence":"It therefore appears that ps myosin heavy chain pe and ps actin pe multigene families are both expressed in a species specific fashion but are independently regulated within a species.","label":1}
{"pair_id":"AIMed.d183.s1553.p0","sentence":"ps JAK2 pe, a member of the Janus kinase superfamily was found to interact functionally with ps Raf-1 pe, a central component of the ras\/mitogen-activated protein kinase signal transduction pathway.","label":1}
{"pair_id":"AIMed.d183.s1553.p1","sentence":"ps JAK2 pe, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ps ras pe\/mitogen-activated protein kinase signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p2","sentence":"ps JAK2 pe, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ras\/ps mitogen-activated protein kinase pe signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p3","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with ps Raf-1 pe, a central component of the ps ras pe\/mitogen-activated protein kinase signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p4","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with ps Raf-1 pe, a central component of the ras\/ps mitogen-activated protein kinase pe signal transduction pathway.","label":0}
{"pair_id":"AIMed.d183.s1553.p5","sentence":"JAK2, a member of the Janus kinase superfamily was found to interact functionally with Raf-1, a central component of the ps ras pe\/ps mitogen-activated protein kinase pe signal transduction pathway.","label":0}
{"pair_id":"BioInfer.d568.s0.p0","sentence":"The activation of the ps c-Raf-1-BxB pe-ps ER pe protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p1","sentence":"The activation of the ps c-Raf-1-BxB pe-ER protein leads to an accumulation of high levels of ps cyclin D1 pe protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p2","sentence":"The activation of the ps c-Raf-1-BxB pe-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 ps cyclin-dependent kinase inhibitor pe under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p3","sentence":"The activation of the ps c-Raf-1-BxB pe-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the ps p27Kip1 pe cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p4","sentence":"The activation of the c-Raf-1-BxB-ps ER pe protein leads to an accumulation of high levels of ps cyclin D1 pe protein and a repression of the p27Kip1 cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p5","sentence":"The activation of the c-Raf-1-BxB-ps ER pe protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the p27Kip1 ps cyclin-dependent kinase inhibitor pe under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p6","sentence":"The activation of the c-Raf-1-BxB-ps ER pe protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the ps p27Kip1 pe cyclin-dependent kinase inhibitor under all culture conditions tested.","label":1}
{"pair_id":"BioInfer.d568.s0.p7","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of ps cyclin D1 pe protein and a repression of the p27Kip1 ps cyclin-dependent kinase inhibitor pe under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p8","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of ps cyclin D1 pe protein and a repression of the ps p27Kip1 pe cyclin-dependent kinase inhibitor under all culture conditions tested.","label":0}
{"pair_id":"BioInfer.d568.s0.p9","sentence":"The activation of the c-Raf-1-BxB-ER protein leads to an accumulation of high levels of cyclin D1 protein and a repression of the ps p27Kip1 pe ps cyclin-dependent kinase inhibitor pe under all culture conditions tested.","label":1}
{"pair_id":"AIMed.d26.s218.p0","sentence":"In contrast, cancer patients exhibited significantly decreased levels of ps granulysin pe expression ( P<0.005), despite having equally high levels of ps perforin pe expression in comparison with healthy controls.","label":0}
{"pair_id":"BioInfer.d100.s0.p0","sentence":"Biochemical complementation experiments also indicate that the ps PRP9 pe and ps PRP11 pe proteins interact.","label":1}
{"pair_id":"AIMed.d199.s1698.p0","sentence":"Activation of ps FGFR3 pe upon ligand binding resulted in activation of ps mitogen-activated protein kinase pe pathway.","label":0}
{"pair_id":"AIMed.d76.s645.p0","sentence":"No binding between ps p59fyn pe(T) and ps CD5 pe was detected in T cells.","label":0}
{"pair_id":"AIMed.d151.s1286.p0","sentence":"We now report the isolation and expression of cDNAs encoding ps PTF pe gamma and ps PTF pe delta, as well as functional studies with cognate antibodies that recognize the native PTF complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d151.s1286.p1","sentence":"We now report the isolation and expression of cDNAs encoding ps PTF pe gamma and PTF delta, as well as functional studies with cognate antibodies that recognize the native ps PTF pe complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d151.s1286.p2","sentence":"We now report the isolation and expression of cDNAs encoding PTF gamma and ps PTF pe delta, as well as functional studies with cognate antibodies that recognize the native ps PTF pe complex in HeLa extracts.","label":0}
{"pair_id":"AIMed.d187.s1590.p0","sentence":"In physiological buffers and CSF, ps TTR pe exclusively decreased the level of ps A beta pe pentamers.","label":0}
{"pair_id":"BioInfer.d430.s1.p0","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of ps E-cadherin pe, alpha-catenin and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d430.s1.p1","sentence":"One complex is composed of E-cadherin, ps alpha- pe and beta-ps catenin pe, the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p2","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of ps E-cadherin pe, ps alpha-catenin pe and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p3","sentence":"One complex is composed of ps E-cadherin pe, alpha- and beta-catenin, the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p4","sentence":"One complex is composed of E-cadherin, alpha- and ps beta-catenin pe, the other of ps E-cadherin pe, alpha-catenin and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p5","sentence":"One complex is composed of E-cadherin, ps alpha- pe and beta-ps catenin pe, the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d430.s1.p6","sentence":"One complex is composed of E-cadherin, alpha- and beta-catenin, the other of E-cadherin, ps alpha-catenin pe and ps plakoglobin pe.","label":1}
{"pair_id":"BioInfer.d430.s1.p7","sentence":"One complex is composed of ps E-cadherin pe, alpha- and beta-catenin, the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d430.s1.p8","sentence":"One complex is composed of E-cadherin, alpha- and ps beta-catenin pe, the other of E-cadherin, alpha-catenin and ps plakoglobin pe.","label":0}
{"pair_id":"BioInfer.d430.s1.p9","sentence":"One complex is composed of E-cadherin, ps alpha- pe and beta-ps catenin pe, the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p10","sentence":"One complex is composed of ps E-cadherin pe, ps alpha- pe and beta-ps catenin pe, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p11","sentence":"One complex is composed of E-cadherin, ps alpha- pe and ps beta-catenin peps catenin pe, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d430.s1.p12","sentence":"One complex is composed of ps E-cadherin pe, alpha- and beta-catenin, the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p13","sentence":"One complex is composed of E-cadherin, alpha- and ps beta-catenin pe, the other of E-cadherin, ps alpha-catenin pe and plakoglobin.","label":0}
{"pair_id":"BioInfer.d430.s1.p14","sentence":"One complex is composed of ps E-cadherin pe, alpha- and ps beta-catenin pe, the other of E-cadherin, alpha-catenin and plakoglobin.","label":1}
{"pair_id":"BioInfer.d452.s0.p0","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the ps actin-binding proteins pe, ps profilin pe, and gelsolin.","label":1}
{"pair_id":"BioInfer.d452.s0.p1","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of ps actin pe assembly through its association with the ps actin-binding proteins pe, profilin, and gelsolin.","label":0}
{"pair_id":"BioInfer.d452.s0.p2","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the ps actin-binding proteins pe, profilin, and ps gelsolin pe.","label":1}
{"pair_id":"BioInfer.d452.s0.p3","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of ps actin pe assembly through its association with the actin-binding proteins, ps profilin pe, and gelsolin.","label":1}
{"pair_id":"BioInfer.d452.s0.p4","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of actin assembly through its association with the actin-binding proteins, ps profilin pe, and ps gelsolin pe.","label":0}
{"pair_id":"BioInfer.d452.s0.p5","sentence":"N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of ps actin pe assembly through its association with the actin-binding proteins, profilin, and ps gelsolin pe.","label":1}
{"pair_id":"BioInfer.d515.s0.p0","sentence":"Regulation of ps myosin heavy chain pe and ps actin pe isogenes during cardiac growth and hypertrophy.","label":0}
{"pair_id":"BioInfer.d65.s1.p0","sentence":"The cellular tumor antigen ps p53 pe is bound to the simian virus 40 (SV40) ps large T-antigen pe in SV40-infected and -transformed cells.","label":1}
{"pair_id":"AIMed.d33.s278.p0","sentence":"A van't Hoff plot of the change in Kd was linear between 10 and 37 degrees C and yielded values of DeltaH degrees = -12.9 kcal\/mol and DeltaS degrees = -15.9 cal mol-1 deg-1, suggesting that electrostatic forces play a prominent role in the interaction of ps C8 pe with ps C9 pe.","label":1}
{"pair_id":"BioInfer.d828.s0.p0","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue ps mgt1 pedelta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p1","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, ps MSH6 pe, and PMS1, did not rescue mgt1delta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p2","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and ps PMS1 pe, did not rescue mgt1delta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p3","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, ps MSH2 pe, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p4","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, ps MSH3 pe, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p5","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair ps methyltransferase pe-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p6","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, ps MSH6 pe, and PMS1, did not rescue ps mgt1 pedelta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p7","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and ps PMS1 pe, did not rescue ps mgt1 pedelta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p8","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, ps MSH2 pe, MSH3, MSH6, and PMS1, did not rescue ps mgt1 pedelta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p9","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, ps MSH3 pe, MSH6, and PMS1, did not rescue ps mgt1 pedelta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p10","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, MSH2, MSH3, MSH6, and PMS1, did not rescue ps mgt1 pedelta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p11","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, ps MSH6 pe, and ps PMS1 pe, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p12","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, ps MSH2 pe, MSH3, ps MSH6 pe, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p13","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, ps MSH3 pe, ps MSH6 pe, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p14","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, MSH2, MSH3, ps MSH6 pe, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p15","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, ps MSH2 pe, MSH3, MSH6, and ps PMS1 pe, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p16","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, ps MSH3 pe, MSH6, and ps PMS1 pe, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p17","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, MSH2, MSH3, MSH6, and ps PMS1 pe, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p18","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, ps MSH2 pe, ps MSH3 pe, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p19","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, ps MSH2 pe, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"BioInfer.d828.s0.p20","sentence":"We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including ps MLH1 pe, MSH2, ps MSH3 pe, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.","label":0}
{"pair_id":"AIMed.d113.s960.p0","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to ps Bcl-2 pe-independent pathways may instead reflect a need for the combination of ps Bcl-2 pe and BAG-1.","label":0}
{"pair_id":"AIMed.d113.s960.p1","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to ps Bcl-2 pe-independent pathways may instead reflect a need for the combination of Bcl-2 and ps BAG-1 pe.","label":0}
{"pair_id":"AIMed.d113.s960.p2","sentence":"The findings indicate that bag-1 represents a new type of anti-cell death gene and suggest that some routes of apoptosis induction previously ascribed to Bcl-2-independent pathways may instead reflect a need for the combination of ps Bcl-2 pe and ps BAG-1 pe.","label":0}
{"pair_id":"BioInfer.d178.s0.p0","sentence":"DNA sequence analysis of the ps cdc3+ pe gene reveals that it encodes ps profilin pe, an actin-monomer-binding protein.","label":1}
{"pair_id":"BioInfer.d178.s0.p1","sentence":"DNA sequence analysis of the cdc3+ gene reveals that it encodes ps profilin pe, an ps actin pe-monomer-binding protein.","label":1}
{"pair_id":"BioInfer.d178.s0.p2","sentence":"DNA sequence analysis of the ps cdc3+ pe gene reveals that it encodes profilin, an ps actin pe-monomer-binding protein.","label":0}
{"pair_id":"AIMed.d104.s879.p0","sentence":"The first cDNA from the ps E2F pe family to be cloned was designated ps E2F-1 pe, and multiple E2F family members have now been identified.","label":0}
{"pair_id":"AIMed.d104.s879.p1","sentence":"The first cDNA from the ps E2F pe family to be cloned was designated E2F-1, and multiple ps E2F pe family members have now been identified.","label":0}
{"pair_id":"AIMed.d104.s879.p2","sentence":"The first cDNA from the E2F family to be cloned was designated ps E2F-1 pe, and multiple ps E2F pe family members have now been identified.","label":0}
{"pair_id":"AIMed.d207.s1787.p0","sentence":"ps MyoD pe prevents ps cyclinA pe\/cdk2 containing E2F complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p1","sentence":"ps MyoD pe prevents cyclinA\/ps cdk2 pe containing E2F complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p2","sentence":"ps MyoD pe prevents cyclinA\/cdk2 containing ps E2F pe complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p3","sentence":"MyoD prevents ps cyclinA pe\/ps cdk2 pe containing E2F complexes formation in terminally differentiated myocytes.","label":1}
{"pair_id":"AIMed.d207.s1787.p4","sentence":"MyoD prevents ps cyclinA pe\/cdk2 containing ps E2F pe complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"AIMed.d207.s1787.p5","sentence":"MyoD prevents cyclinA\/ps cdk2 pe containing ps E2F pe complexes formation in terminally differentiated myocytes.","label":0}
{"pair_id":"BioInfer.d406.s0.p0","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes ps MLH1 pe, MSH2, MSH3, and ps MSH6 pe (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p1","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, ps MSH3 pe, and ps MSH6 pe (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p2","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, ps MSH2 pe, MSH3, and ps MSH6 pe (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p3","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, MSH3, and ps MSH6 pe (ps GTBP pe) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p4","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes ps MLH1 pe, MSH2, ps MSH3 pe, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p5","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes ps MLH1 pe, ps MSH2 pe, MSH3, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p6","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes ps MLH1 pe, MSH2, MSH3, and MSH6 (ps GTBP pe) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p7","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, ps MSH2 pe, ps MSH3 pe, and MSH6 (GTBP) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p8","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, MSH2, ps MSH3 pe, and MSH6 (ps GTBP pe) was investigated.","label":0}
{"pair_id":"BioInfer.d406.s0.p9","sentence":"Linkage between cancer susceptibility and the candidate DNA mismatch repair genes MLH1, ps MSH2 pe, MSH3, and MSH6 (ps GTBP pe) was investigated.","label":0}
{"pair_id":"AIMed.d17.s147.p0","sentence":"In addition, a possible role for ps Gas6 pe, the product of ps growth arrest-specific gene 6 pe, in atherosclerotic lesion development is put into perspective.","label":0}
{"pair_id":"BioInfer.d712.s0.p0","sentence":"These results suggest that ps profilin pe may be involved in the pathogenesis of glomerulonephritis by reorganizing ps actin pe cytoskeleton.","label":1}
{"pair_id":"BioInfer.d379.s1.p0","sentence":"Redundancy of Saccharomyces cerevisiae ps MSH3 pe and MSH6 in ps MSH2 pe-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d379.s1.p1","sentence":"Redundancy of Saccharomyces cerevisiae MSH3 and ps MSH6 pe in ps MSH2 pe-dependent mismatch repair.","label":0}
{"pair_id":"BioInfer.d379.s1.p2","sentence":"Redundancy of Saccharomyces cerevisiae ps MSH3 pe and ps MSH6 pe in MSH2-dependent mismatch repair.","label":0}
{"pair_id":"AIMed.d2.s17.p0","sentence":"The molar ratio of serum ps retinol-binding protein pe (ps RBP pe) to transthyretin (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p1","sentence":"The molar ratio of serum ps retinol-binding protein pe (RBP) to ps transthyretin pe (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p2","sentence":"The molar ratio of serum ps retinol-binding protein pe (RBP) to transthyretin (ps TTR pe) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p3","sentence":"The molar ratio of serum retinol-binding protein (ps RBP pe) to ps transthyretin pe (TTR) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p4","sentence":"The molar ratio of serum retinol-binding protein (ps RBP pe) to transthyretin (ps TTR pe) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"AIMed.d2.s17.p5","sentence":"The molar ratio of serum retinol-binding protein (RBP) to ps transthyretin pe (ps TTR pe) is not useful to assess vitamin A status during infection in hospitalised children.","label":0}
{"pair_id":"BioInfer.d372.s0.p0","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ps ICSBP pe.","label":1}
{"pair_id":"BioInfer.d372.s0.p1","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the ps CREBbinding protein pe), to the CYBB or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p2","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p3","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by PU.1, ps IRF1 pe, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p4","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the CREBbinding protein), to the CYBB or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p5","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the ps CYBB pe or ps NCF2 pe promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p6","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the ps CREBbinding protein pe), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ps ICSBP pe.","label":0}
{"pair_id":"BioInfer.d372.s0.p7","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, IRF1, and ps ICSBP pe.","label":0}
{"pair_id":"BioInfer.d372.s0.p8","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, ps IRF1 pe, and ps ICSBP pe.","label":0}
{"pair_id":"BioInfer.d372.s0.p9","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ps ICSBP pe.","label":0}
{"pair_id":"BioInfer.d372.s0.p10","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the ps CYBB pe or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ps ICSBP pe.","label":1}
{"pair_id":"BioInfer.d372.s0.p11","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the ps CREBbinding protein pe), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p12","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the ps CREBbinding protein pe), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, ps IRF1 pe, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p13","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the ps CREBbinding protein pe), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p14","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the ps CREBbinding protein pe), to the ps CYBB pe or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p15","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, ps IRF1 pe, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p16","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, IRF1, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p17","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the ps CYBB pe or NCF2 promoter is the molecular mechanism of transcriptional activation by ps PU.1 pe, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p18","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the CREBbinding protein), to the CYBB or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, ps IRF1 pe, and ICSBP.","label":0}
{"pair_id":"BioInfer.d372.s0.p19","sentence":"In these investigations, we determine that recruitment of a coactivator protein, CBP (the CREBbinding protein), to the ps CYBB pe or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, ps IRF1 pe, and ICSBP.","label":1}
{"pair_id":"BioInfer.d372.s0.p20","sentence":"In these investigations, we determine that recruitment of a coactivator protein, ps CBP pe (the CREBbinding protein), to the ps CYBB pe or NCF2 promoter is the molecular mechanism of transcriptional activation by PU.1, IRF1, and ICSBP.","label":1}
{"pair_id":"BioInfer.d420.s0.p0","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, ps beta-catenin pe and plakoglobin and a polyclonal antibody against ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d420.s0.p1","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against ps E-cadherin pe, ps beta-catenin pe and plakoglobin and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"BioInfer.d420.s0.p2","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, ps beta-catenin pe and ps plakoglobin pe and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"BioInfer.d420.s0.p3","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against ps E-cadherin pe, beta-catenin and plakoglobin and a polyclonal antibody against ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d420.s0.p4","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and ps plakoglobin pe and a polyclonal antibody against ps alpha-catenin pe.","label":0}
{"pair_id":"BioInfer.d420.s0.p5","sentence":"METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against ps E-cadherin pe, beta-catenin and ps plakoglobin pe and a polyclonal antibody against alpha-catenin.","label":0}
{"pair_id":"AIMed.d126.s1072.p0","sentence":"The rates of commitment to renaturation of ps rhodanese pe and ps glutamine synthetase pe in the presence of the groE chaperonins.","label":0}
{"pair_id":"AIMed.d190.s1611.p0","sentence":"Hemopoietic cell proliferation is mediated by non-tyrosine and tyrosine kinases that signal via uncommon and common sets of downstream effector molecules including the ps Grb2 pe\/ps c-Cbl pe.","label":0}
{"pair_id":"BioInfer.d427.s0.p0","sentence":"ps MLL pe is fused in-frame to a different exon of ps CBP pe in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p1","sentence":"ps MLL pe is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d427.s0.p2","sentence":"ps MLL pe is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the ps CREB pe binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p3","sentence":"ps MLL pe is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of ps MLL pe fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p4","sentence":"ps MLL pe is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, ps methyltransferase pe homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p5","sentence":"MLL is fused in-frame to a different exon of ps CBP pe in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d427.s0.p6","sentence":"MLL is fused in-frame to a different exon of ps CBP pe in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the ps CREB pe binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p7","sentence":"MLL is fused in-frame to a different exon of ps CBP pe in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of ps MLL pe fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p8","sentence":"MLL is fused in-frame to a different exon of ps CBP pe in two patients producing chimeric proteins containing the AT-hooks, ps methyltransferase pe homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p9","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of MLL fused to the ps CREB pe binding domain or to the bromodomain of ps CBP pe.","label":1}
{"pair_id":"BioInfer.d427.s0.p10","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of ps MLL pe fused to the CREB binding domain or to the bromodomain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d427.s0.p11","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, ps methyltransferase pe homology domain, and transcriptional repression domain of MLL fused to the CREB binding domain or to the bromodomain of ps CBP pe.","label":0}
{"pair_id":"BioInfer.d427.s0.p12","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, methyltransferase homology domain, and transcriptional repression domain of ps MLL pe fused to the ps CREB pe binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p13","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, ps methyltransferase pe homology domain, and transcriptional repression domain of MLL fused to the ps CREB pe binding domain or to the bromodomain of CBP.","label":0}
{"pair_id":"BioInfer.d427.s0.p14","sentence":"MLL is fused in-frame to a different exon of CBP in two patients producing chimeric proteins containing the AT-hooks, ps methyltransferase pe homology domain, and transcriptional repression domain of ps MLL pe fused to the CREB binding domain or to the bromodomain of CBP.","label":1}
{"pair_id":"BioInfer.d413.s0.p0","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (Myh) predicted to interfere strongly with ps myosin pe's binding to ps actin pe was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p1","sentence":"MATERIALS AND METHODS: A mutation in the ps myosin heavy chain pe (Myh) predicted to interfere strongly with ps myosin pe's binding to actin was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p2","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (ps Myh pe) predicted to interfere strongly with ps myosin pe's binding to actin was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p3","sentence":"MATERIALS AND METHODS: A mutation in the ps myosin heavy chain pe (Myh) predicted to interfere strongly with myosin's binding to ps actin pe was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p4","sentence":"MATERIALS AND METHODS: A mutation in the myosin heavy chain (ps Myh pe) predicted to interfere strongly with myosin's binding to ps actin pe was designed and used to create an animal model for HCM.","label":1}
{"pair_id":"BioInfer.d413.s0.p5","sentence":"MATERIALS AND METHODS: A mutation in the ps myosin heavy chain pe (ps Myh pe) predicted to interfere strongly with myosin's binding to actin was designed and used to create an animal model for HCM.","label":0}
{"pair_id":"AIMed.d185.s1572.p0","sentence":"In all cells tested, ps IL-10 pe activated ps Stat1 pe and Stat3 and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":1}
{"pair_id":"AIMed.d185.s1572.p1","sentence":"In all cells tested, ps IL-10 pe activated Stat1 and ps Stat3 pe and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":1}
{"pair_id":"AIMed.d185.s1572.p2","sentence":"In all cells tested, IL-10 activated ps Stat1 pe and ps Stat3 pe and induced the formation of three distinct DNA binding complexes that contained different combinations of these two transcription factors.","label":0}
{"pair_id":"BioInfer.d395.s1.p0","sentence":"Native ps profilin pe, purified from extracts of lung epithelial cells by affinity binding to a poly-L-proline matrix, stimulated the ps actin pe-saturated RSV transcription by 2.5- to 3-fold.","label":1}
{"pair_id":"AIMed.d150.s1274.p0","sentence":"The ps retinoblastoma pe gene product (ps Rb pe) is a nuclear phosphoprotein that regulates cell cycle progression.","label":0}
{"pair_id":"AIMed.d219.s1903.p0","sentence":"Recent studies indicate that the structural integrity of the ps Raf-CRD pe is also critical for ps Raf-1 pe interaction with 14-3-3 proteins.","label":0}
{"pair_id":"AIMed.d197.s1676.p0","sentence":"The interaction between ps interleukin-6 pe (ps IL-6 pe) and IL-6 receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p1","sentence":"The interaction between ps interleukin-6 pe (IL-6) and ps IL-6 pe receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p2","sentence":"The interaction between ps interleukin-6 pe (IL-6) and ps IL-6 receptor pe (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p3","sentence":"The interaction between ps interleukin-6 pe (IL-6) and IL-6 receptor (ps IL-6R pe) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p4","sentence":"The interaction between ps interleukin-6 pe (IL-6) and IL-6 receptor (IL-6R) is the initial and most specific step in the ps IL-6 pe signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p5","sentence":"The interaction between interleukin-6 (ps IL-6 pe) and ps IL-6 pe receptor (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p6","sentence":"The interaction between interleukin-6 (ps IL-6 pe) and ps IL-6 receptor pe (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p7","sentence":"The interaction between interleukin-6 (ps IL-6 pe) and IL-6 receptor (ps IL-6R pe) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p8","sentence":"The interaction between interleukin-6 (ps IL-6 pe) and IL-6 receptor (IL-6R) is the initial and most specific step in the ps IL-6 pe signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p9","sentence":"The interaction between interleukin-6 (IL-6) and ps IL-6 peps IL-6 receptor pe (IL-6R) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p10","sentence":"The interaction between interleukin-6 (IL-6) and ps IL-6 pe receptor (ps IL-6R pe) is the initial and most specific step in the IL-6 signaling pathway.","label":1}
{"pair_id":"AIMed.d197.s1676.p11","sentence":"The interaction between interleukin-6 (IL-6) and ps IL-6 pe receptor (IL-6R) is the initial and most specific step in the ps IL-6 pe signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p12","sentence":"The interaction between interleukin-6 (IL-6) and ps IL-6 receptor pe (ps IL-6R pe) is the initial and most specific step in the IL-6 signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p13","sentence":"The interaction between interleukin-6 (IL-6) and ps IL-6 receptor pe (IL-6R) is the initial and most specific step in the ps IL-6 pe signaling pathway.","label":0}
{"pair_id":"AIMed.d197.s1676.p14","sentence":"The interaction between interleukin-6 (IL-6) and IL-6 receptor (ps IL-6R pe) is the initial and most specific step in the ps IL-6 pe signaling pathway.","label":0}
{"pair_id":"AIMed.d76.s641.p0","sentence":"In this study, we demonstrate that ps CD5 pe is coupled to the protein-tyrosine kinase ps p56lck pe and can act as a substrate for p56lck.","label":1}
{"pair_id":"AIMed.d76.s641.p1","sentence":"In this study, we demonstrate that ps CD5 pe is coupled to the protein-tyrosine kinase p56lck and can act as a substrate for ps p56lck pe.","label":1}
{"pair_id":"AIMed.d76.s641.p2","sentence":"In this study, we demonstrate that CD5 is coupled to the protein-tyrosine kinase ps p56lck pe and can act as a substrate for ps p56lck pe.","label":0}
{"pair_id":"BioInfer.d292.s0.p0","sentence":"Immunohistochemical investigation of ps actin pe-anchoring proteins vinculin, talin and ps paxillin pe in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p1","sentence":"Immunohistochemical investigation of ps actin pe-anchoring proteins vinculin, ps talin pe and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p2","sentence":"Immunohistochemical investigation of ps actin pe-anchoring proteins ps vinculin pe, talin and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":1}
{"pair_id":"BioInfer.d292.s0.p3","sentence":"Immunohistochemical investigation of actin-anchoring proteins vinculin, ps talin pe and ps paxillin pe in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"BioInfer.d292.s0.p4","sentence":"Immunohistochemical investigation of actin-anchoring proteins ps vinculin pe, talin and ps paxillin pe in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"BioInfer.d292.s0.p5","sentence":"Immunohistochemical investigation of actin-anchoring proteins ps vinculin pe, ps talin pe and paxillin in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.","label":0}
{"pair_id":"AIMed.d102.s864.p0","sentence":"The stimulation of ps Sp1 pe-mediated transcription by ps RB pe in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human TAFII250.","label":0}
{"pair_id":"AIMed.d102.s864.p1","sentence":"The stimulation of ps Sp1 pe-mediated transcription by RB in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human ps TAFII250 pe.","label":0}
{"pair_id":"AIMed.d102.s864.p2","sentence":"The stimulation of Sp1-mediated transcription by ps RB pe in ts13 cells at the nonpermissive temperature could be restored by the introduction of wild-type human ps TAFII250 pe.","label":0}
{"pair_id":"AIMed.d128.s1099.p0","sentence":"Comparisons with the ps hGH pe-ps hGHR pe complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.","label":1}
{"pair_id":"AIMed.d128.s1099.p1","sentence":"Comparisons with the ps hGH pe-hGHR complex reveal how ps hGH pe can bind to the two distinctly different receptor binding surfaces.","label":0}
{"pair_id":"AIMed.d128.s1099.p2","sentence":"Comparisons with the hGH-ps hGHR pe complex reveal how ps hGH pe can bind to the two distinctly different receptor binding surfaces.","label":0}
{"pair_id":"BioInfer.d713.s1.p0","sentence":"We report here that LIMK1 and ps LIMK2 pe phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed ps cofilin pe mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p1","sentence":"We report here that ps LIMK1 pe and ps LIMK2 pe phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p2","sentence":"We report here that LIMK1 and ps LIMK2 pe phosphorylate both cofilin and actin-depolymerizing factor (ps ADF pe) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p3","sentence":"We report here that LIMK1 and ps LIMK2 pe phosphorylate both ps cofilin pe and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p4","sentence":"We report here that LIMK1 and ps LIMK2 pe phosphorylate both cofilin and ps actin-depolymerizing factor pe (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p5","sentence":"We report here that ps LIMK1 pe and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed ps cofilin pe mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p6","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ps ADF pe) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed ps cofilin pe mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p7","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both ps cofilin pe and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed ps cofilin pe mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p8","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and ps actin-depolymerizing factor pe (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed ps cofilin pe mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p9","sentence":"We report here that ps LIMK1 pe and LIMK2 phosphorylate both cofilin and actin-depolymerizing factor (ps ADF pe) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p10","sentence":"We report here that ps LIMK1 pe and LIMK2 phosphorylate both ps cofilin pe and actin-depolymerizing factor (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p11","sentence":"We report here that ps LIMK1 pe and LIMK2 phosphorylate both cofilin and ps actin-depolymerizing factor pe (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":1}
{"pair_id":"BioInfer.d713.s1.p12","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both ps cofilin pe and actin-depolymerizing factor (ps ADF pe) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p13","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both cofilin and ps actin-depolymerizing factor pe (ps ADF pe) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"BioInfer.d713.s1.p14","sentence":"We report here that LIMK1 and LIMK2 phosphorylate both ps cofilin pe and ps actin-depolymerizing factor pe (ADF) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed cofilin mutants as substrates.","label":0}
{"pair_id":"AIMed.d136.s1154.p0","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of ps IL-15 pe, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p1","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of IL-15, and ps IL-15 pe competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p2","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with ps IL-2 pe, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p3","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that ps IL-15 pe uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p4","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 pe receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p5","sentence":"Monoclonal antibodies to the beta chain of the ps IL-2 pe receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 receptor pe.","label":0}
{"pair_id":"AIMed.d136.s1154.p6","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of ps IL-15 pe, and ps IL-15 pe competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p7","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of ps IL-15 pe, and IL-15 competed for binding with ps IL-2 pe, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p8","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of ps IL-15 pe, and IL-15 competed for binding with IL-2, indicating that ps IL-15 pe uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p9","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of ps IL-15 pe, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 pe receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p10","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of ps IL-15 pe, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 receptor pe.","label":0}
{"pair_id":"AIMed.d136.s1154.p11","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and ps IL-15 pe competed for binding with ps IL-2 pe, indicating that IL-15 uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p12","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and ps IL-15 pe competed for binding with IL-2, indicating that ps IL-15 pe uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p13","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and ps IL-15 pe competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 pe receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p14","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and ps IL-15 pe competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 receptor pe.","label":0}
{"pair_id":"AIMed.d136.s1154.p15","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with ps IL-2 pe, indicating that ps IL-15 pe uses components of the IL-2 receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p16","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with ps IL-2 pe, indicating that IL-15 uses components of the ps IL-2 pe receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p17","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with ps IL-2 pe, indicating that IL-15 uses components of the ps IL-2 receptor pe.","label":0}
{"pair_id":"AIMed.d136.s1154.p18","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that ps IL-15 pe uses components of the ps IL-2 pe receptor.","label":0}
{"pair_id":"AIMed.d136.s1154.p19","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that ps IL-15 pe uses components of the ps IL-2 receptor pe.","label":1}
{"pair_id":"AIMed.d136.s1154.p20","sentence":"Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the ps IL-2 peps IL-2 receptor pe.","label":0}
{"pair_id":"AIMed.d165.s1391.p0","sentence":"Our analyses demonstrate that the ps XPB pe, ps XPD pe, p44, and p62 proteins interact with each other.","label":1}
{"pair_id":"AIMed.d165.s1391.p1","sentence":"Our analyses demonstrate that the ps XPB pe, XPD, ps p44 pe, and p62 proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p2","sentence":"Our analyses demonstrate that the ps XPB pe, XPD, p44, and ps p62 pe proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p3","sentence":"Our analyses demonstrate that the XPB, ps XPD pe, ps p44 pe, and p62 proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p4","sentence":"Our analyses demonstrate that the XPB, ps XPD pe, p44, and ps p62 pe proteins interact with each other.","label":0}
{"pair_id":"AIMed.d165.s1391.p5","sentence":"Our analyses demonstrate that the XPB, XPD, ps p44 pe, and ps p62 pe proteins interact with each other.","label":0}
{"pair_id":"BioInfer.d58.s0.p0","sentence":"Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of ps profilin pe and ps actin pe did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.","label":0}
{"pair_id":"AIMed.d79.s681.p0","sentence":"While the function of ps RIZ pe is not yet clear, its structure and pattern of expression suggest a role for ps RIZ pe in transcriptional regulation during neuronal differentiation and pathogenesis of retinoblastoma.","label":0}
{"pair_id":"AIMed.d85.s718.p0","sentence":"In the second of a series of experiments designed to identify ps p47nck pe-Src homology 3 (SH3)-binding molecules, we report the cloning of ps SAKAP II pe (Src A box Nck-associated protein II) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d85.s718.p1","sentence":"In the second of a series of experiments designed to identify ps p47nck pe-Src homology 3 (SH3)-binding molecules, we report the cloning of SAKAP II (ps Src A box Nck-associated protein II pe) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d85.s718.p2","sentence":"In the second of a series of experiments designed to identify p47nck-Src homology 3 (SH3)-binding molecules, we report the cloning of ps SAKAP II pe (ps Src A box Nck-associated protein II pe) from an HL60 cDNA expression library.","label":0}
{"pair_id":"AIMed.d53.s471.p0","sentence":"Unlike human ps IL-6 pe (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact ps gp130 pe, which enhances the complementarity of the viral IL-6-gp130 binding interfaces.","label":1}
{"pair_id":"AIMed.d53.s471.p1","sentence":"Unlike human ps IL-6 pe (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral ps IL-6 pe-gp130 binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p2","sentence":"Unlike human ps IL-6 pe (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral IL-6-ps gp130 pe binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p3","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact ps gp130 pe, which enhances the complementarity of the viral ps IL-6 pe-gp130 binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p4","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact ps gp130 pe, which enhances the complementarity of the viral IL-6-ps gp130 pe binding interfaces.","label":0}
{"pair_id":"AIMed.d53.s471.p5","sentence":"Unlike human IL-6 (which uses many hydrophilic residues), the viral cytokine largely uses hydrophobic amino acids to contact gp130, which enhances the complementarity of the viral ps IL-6 pe-ps gp130 pe binding interfaces.","label":1}
{"pair_id":"BioInfer.d495.s0.p0","sentence":"Profilin I and ps profilin II pe have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric ps actin pe to the same extent.","label":1}
{"pair_id":"BioInfer.d495.s0.p1","sentence":"ps Profilin I pe and profilin II have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric ps actin pe to the same extent.","label":1}
{"pair_id":"BioInfer.d495.s0.p2","sentence":"ps Profilin I pe and ps profilin II pe have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric actin to the same extent.","label":1}
{"pair_id":"AIMed.d12.s103.p0","sentence":"RESULTS: In the blister fluid of patients with TEN, we found significantly higher levels of ps sIL-2R pe than in patients with burns, whereas ps IL-1alpha pe levels were higher in the blister fluid of burned patients.","label":0}
{"pair_id":"BioInfer.d433.s0.p0","sentence":"Monoclonal antibodies recognizing the N- and C-terminal regions of ps talin pe disrupt ps actin pe stress fibers when microinjected into human fibroblasts.","label":1}
{"pair_id":"AIMed.d57.s508.p0","sentence":"The native and reconstituted ps pp60src pe-ps hsp90 pe complexes have similar thermal stability and, like steroid receptor heterocomplexes, they are stabilized by molybdate.","label":1}
{"pair_id":"BioInfer.d269.s0.p0","sentence":"However, immunofluorescence staining revealed a similar organisation of ps actin pe microfilaments, ps talin pe and phosphotyrosyl-containing proteins on both substrates.","label":0}
{"pair_id":"BioInfer.d5.s2.p0","sentence":"Since the NH2 terminus of ps profilin pe is blocked, Edman degradation gave only the sequence of the conjugated ps actin pe CNBr fragment beginning with Trp-356.","label":0}
{"pair_id":"AIMed.d118.s996.p0","sentence":"The ps p21 pe inhibitor of cyclin-dependent kinases controls DNA replication by interaction with ps PCNA pe.","label":1}
{"pair_id":"AIMed.d169.s1430.p0","sentence":"The ps IL-13R pe shows homology with the ps IL-5 pe receptor, and to a lesser extent, with the prolactin receptor.","label":0}
{"pair_id":"AIMed.d165.s1392.p0","sentence":"ps XPG pe protein interacts with multiple subunits of ps TFIIH pe and with CSB protein.","label":0}
{"pair_id":"AIMed.d165.s1392.p1","sentence":"ps XPG pe protein interacts with multiple subunits of TFIIH and with ps CSB pe protein.","label":1}
{"pair_id":"AIMed.d165.s1392.p2","sentence":"XPG protein interacts with multiple subunits of ps TFIIH pe and with ps CSB pe protein.","label":0}
{"pair_id":"BioInfer.d746.s0.p0","sentence":"This shows that structural changes in the poly(L-proline)-binding region of ps profilin pe can affect the distantly located ps actin pe-binding site.","label":1}
{"pair_id":"BioInfer.d819.s0.p0","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the ps villin pe and fimbrin from the cores but does not affect actin binding by 110-kD ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d819.s0.p1","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the ps villin pe and ps fimbrin pe from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p2","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the ps villin pe and fimbrin from the cores but does not affect ps actin pe binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p3","sentence":"We report here that ps tropomyosin pe, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the ps villin pe and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p4","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the ps actin pe of isolated cores, and can cause the dissociation of up to 30% of the ps villin pe and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p5","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and ps fimbrin pe from the cores but does not affect actin binding by 110-kD ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d819.s0.p6","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect ps actin pe binding by 110-kD ps calmodulin pe.","label":1}
{"pair_id":"BioInfer.d819.s0.p7","sentence":"We report here that ps tropomyosin pe, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD ps calmodulin pe.","label":1}
{"pair_id":"BioInfer.d819.s0.p8","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the ps actin pe of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d819.s0.p9","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and ps fimbrin pe from the cores but does not affect ps actin pe binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p10","sentence":"We report here that ps tropomyosin pe, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and ps fimbrin pe from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p11","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the ps actin pe of isolated cores, and can cause the dissociation of up to 30% of the villin and ps fimbrin pe from the cores but does not affect actin binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p12","sentence":"We report here that ps tropomyosin pe, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect ps actin pe binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d819.s0.p13","sentence":"We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the ps actin pe of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect ps actin pe binding by 110-kD calmodulin.","label":0}
{"pair_id":"BioInfer.d819.s0.p14","sentence":"We report here that ps tropomyosin pe, which is found in the rootlet but not in the microvillus core, can bind to and saturate the ps actin pe of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.","label":1}
{"pair_id":"BioInfer.d71.s0.p0","sentence":"ps RAD51 pe, ps RAD52 pe, and RAD54 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d71.s0.p1","sentence":"RAD51, ps RAD52 pe, and ps RAD54 pe encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d71.s0.p2","sentence":"ps RAD51 pe, RAD52, and ps RAD54 pe encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.","label":0}
{"pair_id":"BioInfer.d432.s1.p0","sentence":"Other ps actin pe-associated proteins, including ps vinculin pe, talin, and ezrin, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p1","sentence":"Other actin-associated proteins, including ps vinculin pe, talin, and ps ezrin pe, are not present.","label":0}
{"pair_id":"BioInfer.d432.s1.p2","sentence":"Other actin-associated proteins, including ps vinculin pe, ps talin pe, and ezrin, are not present.","label":0}
{"pair_id":"BioInfer.d432.s1.p3","sentence":"Other ps actin pe-associated proteins, including vinculin, talin, and ps ezrin pe, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p4","sentence":"Other ps actin pe-associated proteins, including vinculin, ps talin pe, and ezrin, are not present.","label":1}
{"pair_id":"BioInfer.d432.s1.p5","sentence":"Other actin-associated proteins, including vinculin, ps talin pe, and ps ezrin pe, are not present.","label":0}
{"pair_id":"AIMed.d87.s734.p0","sentence":"Interaction of the ps p85 pe subunit of ps PI 3-kinase pe with the insulin receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p1","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the ps insulin pe receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p2","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the ps insulin receptor pe (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p3","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the insulin receptor (ps IR pe) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p4","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the insulin receptor (IR) and the ps IGF-1 pe receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p5","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the insulin receptor (IR) and the ps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p6","sentence":"Interaction of the ps p85 pe subunit of PI 3-kinase with the insulin receptor (IR) and the IGF-1 receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p7","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the ps insulin pe receptor (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p8","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the ps insulin receptor pe (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p9","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the insulin receptor (ps IR pe) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p10","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the insulin receptor (IR) and the ps IGF-1 pe receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p11","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the insulin receptor (IR) and the ps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p12","sentence":"Interaction of the p85 subunit of ps PI 3-kinase pe with the insulin receptor (IR) and the IGF-1 receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":1}
{"pair_id":"AIMed.d87.s734.p13","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin peps insulin receptor pe (IR) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p14","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin pe receptor (ps IR pe) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p15","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin pe receptor (IR) and the ps IGF-1 pe receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p16","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin pe receptor (IR) and the ps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p17","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin pe receptor (IR) and the IGF-1 receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p18","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin receptor pe (ps IR pe) and the IGF-1 receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p19","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin receptor pe (IR) and the ps IGF-1 pe receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p20","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin receptor pe (IR) and the ps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p21","sentence":"Interaction of the p85 subunit of PI 3-kinase with the ps insulin receptor pe (IR) and the IGF-1 receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p22","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (ps IR pe) and the ps IGF-1 pe receptor (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p23","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (ps IR pe) and the ps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p24","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (ps IR pe) and the IGF-1 receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p25","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the ps IGF-1 peps IGF-1 receptor pe (IGF-1R) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p26","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the ps IGF-1 pe receptor (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"AIMed.d87.s734.p27","sentence":"Interaction of the p85 subunit of PI 3-kinase with the insulin receptor (IR) and the ps IGF-1 receptor pe (ps IGF-1R pe) was investigated using the two-hybrid system by assessing for his3 and lacZ activation in S. cerevisiae.","label":0}
{"pair_id":"BioInfer.d112.s0.p0","sentence":"Both types of beads induced the recruitment of ps N-cadherin pe, beta-catenin, ps alpha-catenin pe and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p1","sentence":"Both types of beads induced the recruitment of ps N-cadherin pe, ps beta-catenin pe, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p2","sentence":"Both types of beads induced the recruitment of ps N-cadherin pe, beta-catenin, alpha-catenin and ps p120 pe, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p3","sentence":"Both types of beads induced the recruitment of N-cadherin, ps beta-catenin pe, ps alpha-catenin pe and p120, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p4","sentence":"Both types of beads induced the recruitment of N-cadherin, beta-catenin, ps alpha-catenin pe and ps p120 pe, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d112.s0.p5","sentence":"Both types of beads induced the recruitment of N-cadherin, ps beta-catenin pe, alpha-catenin and ps p120 pe, by lateral mobilization of preexisting cell membrane complexes.","label":0}
{"pair_id":"BioInfer.d535.s0.p0","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p1","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p2","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p3","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p4","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p5","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p6","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p7","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p8","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native ps profilins pe; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p9","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p10","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p11","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p12","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p13","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p14","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p15","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p16","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified ps profilin pe without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p17","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p18","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p19","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p20","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p21","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p22","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p23","sentence":"Several lines of evidence show that the ps profilins pe fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p24","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p25","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p26","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p27","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p28","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p29","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to ps actin pe in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p30","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p31","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p32","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p33","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p34","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed ps profilins pe form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p35","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p36","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p37","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p38","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native ps profilin-I pe; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p39","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p40","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p41","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba ps profilins pe inhibit ps actin pe polymerization.","label":1}
{"pair_id":"BioInfer.d535.s0.p42","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit actin polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p43","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human profilins rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba ps profilin-I pe has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"BioInfer.d535.s0.p44","sentence":"Several lines of evidence show that the profilins fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human ps profilins pe rebind quantitatively to poly-L-proline and bind to actin in the same way as native, conventionally purified profilin without urea treatment; 2) dialyzed profilins form 3-D crystals under the same conditions as native profilins; 3) dialyzed Acanthamoeba profilin-I has an NMR spectrum identical with that of native profilin-I; and 4) dialyzed human and Acanthamoeba profilins inhibit ps actin pe polymerization.","label":0}
{"pair_id":"AIMed.d176.s1493.p0","sentence":"The interactions of ps hsp70 pe and ps hsp90 pe in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":1}
{"pair_id":"AIMed.d176.s1493.p1","sentence":"The interactions of ps hsp70 pe and hsp90 in intermediate ps PR pe complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p2","sentence":"The interactions of ps hsp70 pe and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early ps PR pe complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p3","sentence":"The interactions of ps hsp70 pe and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (ps hsp70 pe) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p4","sentence":"The interactions of ps hsp70 pe and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature ps PR pe complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p5","sentence":"The interactions of hsp70 and ps hsp90 pe in intermediate ps PR pe complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p6","sentence":"The interactions of hsp70 and ps hsp90 pe in intermediate PR complexes are shown to be distinct from their separate interactions in early ps PR pe complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p7","sentence":"The interactions of hsp70 and ps hsp90 pe in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (ps hsp70 pe) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p8","sentence":"The interactions of hsp70 and ps hsp90 pe in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature ps PR pe complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p9","sentence":"The interactions of hsp70 and hsp90 in intermediate ps PR pe complexes are shown to be distinct from their separate interactions in early ps PR pe complexes (hsp70) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p10","sentence":"The interactions of hsp70 and hsp90 in intermediate ps PR pe complexes are shown to be distinct from their separate interactions in early PR complexes (ps hsp70 pe) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p11","sentence":"The interactions of hsp70 and hsp90 in intermediate ps PR pe complexes are shown to be distinct from their separate interactions in early PR complexes (hsp70) or in mature ps PR pe complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p12","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early ps PR pe complexes (ps hsp70 pe) or in mature PR complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p13","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early ps PR pe complexes (hsp70) or in mature ps PR pe complexes (hsp90).","label":0}
{"pair_id":"AIMed.d176.s1493.p14","sentence":"The interactions of hsp70 and hsp90 in intermediate PR complexes are shown to be distinct from their separate interactions in early PR complexes (ps hsp70 pe) or in mature ps PR pe complexes (hsp90).","label":0}
{"pair_id":"AIMed.d190.s1620.p0","sentence":"Taken together our results demonstrate that ps c-Cbl pe plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with ps Grb2 pe\/c-Cbl complex when non-tyrosine or tyrosine kinase receptors are activated.","label":0}
{"pair_id":"AIMed.d190.s1620.p1","sentence":"Taken together our results demonstrate that ps c-Cbl pe plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with Grb2\/ps c-Cbl pe complex when non-tyrosine or tyrosine kinase receptors are activated.","label":0}
{"pair_id":"AIMed.d190.s1620.p2","sentence":"Taken together our results demonstrate that c-Cbl plays an important role in coupling both tyrosine and non-tyrosine kinase receptors to downstream effector molecules and that different signaling molecules interact with ps Grb2 pe\/ps c-Cbl pe complex when non-tyrosine or tyrosine kinase receptors are activated.","label":1}
{"pair_id":"BioInfer.d579.s0.p0","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, UL52, ps SSB pe, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p1","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, ps UL42 pe, UL52, ps SSB pe, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p2","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, ps UL52 pe, ps SSB pe, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p3","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, ps UL8 pe, UL9, UL42, UL52, ps SSB pe, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p4","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, ps UL9 pe, UL42, UL52, ps SSB pe, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p5","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, UL8, UL9, UL42, UL52, ps SSB pe, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p6","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, ps UL42 pe, UL52, SSB, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p7","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, UL42, ps UL52 pe, SSB, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p8","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, ps UL8 pe, UL9, UL42, UL52, SSB, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p9","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, ps UL9 pe, UL42, UL52, SSB, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p10","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, UL8, UL9, UL42, UL52, SSB, and ps Pol pe, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p11","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, UL9, ps UL42 pe, ps UL52 pe, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p12","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, ps UL8 pe, UL9, ps UL42 pe, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p13","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, ps UL9 pe, ps UL42 pe, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p14","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, UL8, UL9, ps UL42 pe, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p15","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, ps UL8 pe, UL9, UL42, ps UL52 pe, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p16","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, UL8, ps UL9 pe, UL42, ps UL52 pe, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p17","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, UL8, UL9, UL42, ps UL52 pe, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p18","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, UL5, ps UL8 pe, ps UL9 pe, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p19","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, ps UL8 pe, UL9, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d579.s0.p20","sentence":"The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, ps UL5 pe, UL8, ps UL9 pe, UL42, UL52, SSB, and Pol, that are essential for viral DNA replication.","label":0}
{"pair_id":"BioInfer.d765.s0.p0","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (ps CKIs pe) ps p27 pe and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p1","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the ps cyclin-dependent kinase inhibitors pe (CKIs) ps p27 pe and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p2","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, ps cyclin D1 pe, the cyclin-dependent kinase inhibitors (CKIs) ps p27 pe and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p3","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) ps p27 pe and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p4","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, ps cyclin B1 pe, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) ps p27 pe and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p5","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) ps p27 pe and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p6","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the ps cyclin-dependent kinase inhibitors pe (ps CKIs pe) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p7","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, ps cyclin D1 pe, the cyclin-dependent kinase inhibitors (ps CKIs pe) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p8","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (ps CKIs pe) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p9","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, ps cyclin B1 pe, cyclin D1, the cyclin-dependent kinase inhibitors (ps CKIs pe) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p10","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (ps CKIs pe) p27 and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p11","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, ps cyclin D1 pe, the ps cyclin-dependent kinase inhibitors pe (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p12","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, cyclin B1, cyclin D1, the ps cyclin-dependent kinase inhibitors pe (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p13","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, ps cyclin B1 pe, cyclin D1, the ps cyclin-dependent kinase inhibitors pe (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p14","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, cyclin D1, the ps cyclin-dependent kinase inhibitors pe (CKIs) p27 and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":1}
{"pair_id":"BioInfer.d765.s0.p15","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, cyclin B1, ps cyclin D1 pe, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p16","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, ps cyclin B1 pe, ps cyclin D1 pe, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p17","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, cyclin B1, ps cyclin D1 pe, the cyclin-dependent kinase inhibitors (CKIs) p27 and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p18","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, ps cyclin B1 pe, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and p57, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p19","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of ps cyclin A pe, cyclin B1, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"BioInfer.d765.s0.p20","sentence":"To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of cyclin A, ps cyclin B1 pe, cyclin D1, the cyclin-dependent kinase inhibitors (CKIs) p27 and ps p57 pe, and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.","label":0}
{"pair_id":"AIMed.d144.s1220.p0","sentence":"In vitro-binding assays demonstrated that ps PP-1 alpha pe isoforms preferentially bind the hypophosphorylated form of ps p110RB pe.","label":1}
{"pair_id":"BioInfer.d772.s0.p0","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, FADD, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p1","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, ps FADD pe, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p2","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p3","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, FADD, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p4","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of ps FLICE pe, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p5","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, FADD, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p6","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, ps Fas pe, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p7","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of ps FLICE pe, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p8","sentence":"Transcriptional expression of TNFR1(p55), as well as that of ps FLICE pe, Fas, FADD, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p9","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, ps FADD pe, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p10","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p11","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, ps FAF pe, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p12","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p13","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, ps DR3 pe, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p14","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, FADD, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p15","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, FADD, DR3, FAF, ps TRADD pe, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p16","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, ps TRADD pe, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p17","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, ps FADD pe, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p18","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, ps FADD pe, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p19","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, ps FADD pe, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p20","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, ps FADD pe, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p21","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, ps FADD pe, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p22","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, ps FADD pe, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p23","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, ps FADD pe, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p24","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p25","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p26","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p27","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p28","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p29","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to ps TNFalpha pe-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":1}
{"pair_id":"BioInfer.d772.s0.p30","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, FADD, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p31","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, ps DR3 pe, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p32","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, FADD, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p33","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, FADD, DR3, ps FAF pe, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p34","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, DR3, ps FAF pe, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p35","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, FADD, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p36","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, ps Fas pe, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p37","sentence":"Transcriptional expression of ps TNFR1 pe(ps p55 pe), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p38","sentence":"Transcriptional expression of ps TNFR1 pe(p55), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p39","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, FADD, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p40","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, FADD, ps DR3 pe, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p41","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, Fas, FADD, ps DR3 pe, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p42","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, ps Fas pe, FADD, DR3, FAF, TRADD, and RIP was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p43","sentence":"Transcriptional expression of TNFR1(p55), as well as that of FLICE, ps Fas pe, FADD, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d772.s0.p44","sentence":"Transcriptional expression of TNFR1(ps p55 pe), as well as that of FLICE, Fas, FADD, DR3, FAF, TRADD, and ps RIP pe was similar in these cell lines, indicating that the susceptibility to TNFalpha-induced apoptosis may not be determined by the constitutive expression level of these factors.","label":0}
{"pair_id":"BioInfer.d560.s0.p0","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p1","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p2","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p3","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p4","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p5","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p6","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p7","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p8","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p9","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p10","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p11","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p12","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p13","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), ps V protein pe, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p14","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p15","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p16","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p17","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p18","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p19","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p20","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p21","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p22","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p23","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p24","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p25","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p26","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), ps phosphoprotein pe (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p27","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p28","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p29","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p30","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p31","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p32","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p33","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p34","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p35","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p36","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p37","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p38","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), ps fusion protein pe (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p39","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p40","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p41","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p42","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p43","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p44","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p45","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p46","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p47","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (ps SH pe) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p48","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p49","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), ps small hydrophobic pe (SH) ps small h pe, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p50","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p51","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p52","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p53","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p54","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p55","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p56","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p57","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p58","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p59","sentence":"The 16236 nt genome encodes eight proteins, ps nucleocapsid protein pe (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p60","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p61","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p62","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p63","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p64","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p65","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p66","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p67","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (L) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p68","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and ps large pe (ps L pe) ps large p pe, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p69","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p70","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p71","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p72","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p73","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p74","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p75","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p76","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (ps M pe), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p77","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p78","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p79","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (ps HN pe) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p80","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p81","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p82","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p83","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (ps HN pe) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p84","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p85","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p86","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p87","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p88","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p89","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (ps NP pe), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p90","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p91","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p92","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p93","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p94","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, ps matrix protein pe (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p95","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p96","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p97","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p98","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, ps haemagglutinin-neuraminidase pe (HN) ps haemagg pe and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p99","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p100","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p101","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (ps P pe), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p102","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (L) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p103","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (ps SH pe) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d560.s0.p104","sentence":"The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (ps F pe), small hydrophobic (SH) small h, haemagglutinin-neuraminidase (HN) haemagg and large (ps L pe) large p, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.","label":0}
{"pair_id":"BioInfer.d175.s1.p0","sentence":"The ps PRT1 pe, TIF34, ps GCD10 pe, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p1","sentence":"The PRT1, TIF34, ps GCD10 pe, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with ps eukaryotic translation initiation factor 3 pe (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p2","sentence":"The PRT1, ps TIF34 pe, ps GCD10 pe, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p3","sentence":"The PRT1, TIF34, ps GCD10 pe, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (ps eIF3 pe) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p4","sentence":"The PRT1, TIF34, ps GCD10 pe, and ps SUI1 pe proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p5","sentence":"The ps PRT1 pe, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with ps eukaryotic translation initiation factor 3 pe (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p6","sentence":"The ps PRT1 pe, ps TIF34 pe, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p7","sentence":"The ps PRT1 pe, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (ps eIF3 pe) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p8","sentence":"The ps PRT1 pe, TIF34, GCD10, and ps SUI1 pe proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p9","sentence":"The PRT1, ps TIF34 pe, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with ps eukaryotic translation initiation factor 3 pe (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p10","sentence":"The PRT1, TIF34, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with ps eukaryotic translation initiation factor 3 pe (ps eIF3 pe) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p11","sentence":"The PRT1, TIF34, GCD10, and ps SUI1 pe proteins of Saccharomyces cerevisiae were found previously to copurify with ps eukaryotic translation initiation factor 3 pe (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p12","sentence":"The PRT1, ps TIF34 pe, GCD10, and SUI1 proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (ps eIF3 pe) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p13","sentence":"The PRT1, ps TIF34 pe, GCD10, and ps SUI1 pe proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (eIF3) activity.","label":0}
{"pair_id":"BioInfer.d175.s1.p14","sentence":"The PRT1, TIF34, GCD10, and ps SUI1 pe proteins of Saccharomyces cerevisiae were found previously to copurify with eukaryotic translation initiation factor 3 (ps eIF3 pe) activity.","label":0}
{"pair_id":"AIMed.d214.s1859.p0","sentence":"This suggests that ps c-Cbl pe may link ps TCR pe activation to molecules that regulate GTP binding proteins.","label":0}
{"pair_id":"BioInfer.d18.s0.p0","sentence":"ps Actin pe isoforms from different species were also compared, and the effect of profilin on the thermal stability of ps actin pe was studied.","label":0}
{"pair_id":"BioInfer.d18.s0.p1","sentence":"ps Actin pe isoforms from different species were also compared, and the effect of ps profilin pe on the thermal stability of actin was studied.","label":0}
{"pair_id":"BioInfer.d18.s0.p2","sentence":"Actin isoforms from different species were also compared, and the effect of ps profilin pe on the thermal stability of ps actin pe was studied.","label":1}
{"pair_id":"BioInfer.d733.s0.p0","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes ps RAD50 pe, RAD51, and ps RAD52 pe for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p1","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, ps RAD51 pe, and ps RAD52 pe for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p2","sentence":"They exhibited strong synergistic increases in ps CAN1 pe duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, RAD51, and ps RAD52 pe for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p3","sentence":"They exhibited strong synergistic increases in CAN1 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes ps RAD50 pe, ps RAD51 pe, and RAD52 for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p4","sentence":"They exhibited strong synergistic increases in ps CAN1 pe duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes ps RAD50 pe, RAD51, and RAD52 for viability.","label":0}
{"pair_id":"BioInfer.d733.s0.p5","sentence":"They exhibited strong synergistic increases in ps CAN1 pe duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes RAD50, ps RAD51 pe, and RAD52 for viability.","label":0}
{"pair_id":"AIMed.d158.s1334.p0","sentence":"Here, we show that ps TRADD pe interacts strongly with ps RIP pe, another death domain protein that was shown previously to associate with Fas antigen.","label":1}
{"pair_id":"AIMed.d158.s1334.p1","sentence":"Here, we show that ps TRADD pe interacts strongly with RIP, another death domain protein that was shown previously to associate with ps Fas pe antigen.","label":0}
{"pair_id":"AIMed.d158.s1334.p2","sentence":"Here, we show that TRADD interacts strongly with ps RIP pe, another death domain protein that was shown previously to associate with ps Fas pe antigen.","label":1}
{"pair_id":"BioInfer.d381.s0.p0","sentence":"In this study we demonstrate that ps histone pe H3 and histone ps H4 pe synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d381.s0.p1","sentence":"In this study we demonstrate that ps histone pe ps H3 pe and histone H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p2","sentence":"In this study we demonstrate that ps histone pe H3 and ps histone pe H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d381.s0.p3","sentence":"In this study we demonstrate that histone ps H3 pe and histone ps H4 pe synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p4","sentence":"In this study we demonstrate that histone H3 and ps histone pe ps H4 pe synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":1}
{"pair_id":"BioInfer.d381.s0.p5","sentence":"In this study we demonstrate that histone ps H3 pe and ps histone pe H4 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.","label":0}
{"pair_id":"BioInfer.d607.s1.p0","sentence":"The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that ps cofilin pe is deeply involved in the regulation of ps actin pe assembly in developing skeletal muscle.","label":1}
{"pair_id":"AIMed.d96.s811.p0","sentence":"In this article, we demonstrate that ps PTPmu pe associates with a complex containing ps cadherins, alpha pe- and beta-catenin in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":0}
{"pair_id":"AIMed.d96.s811.p1","sentence":"In this article, we demonstrate that ps PTPmu pe associates with a complex containing cadherins, alpha- and ps beta-catenin pe in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":1}
{"pair_id":"AIMed.d96.s811.p2","sentence":"In this article, we demonstrate that PTPmu associates with a complex containing ps cadherins, alpha pe- and ps beta-catenin pe in mink lung (MvLu) cells, and in rat heart, lung, and brain tissues.","label":0}
{"pair_id":"AIMed.d143.s1206.p0","sentence":"We have previously identified ps IL-11 pe specific binding protein which is distinct from that of ps IL-6 pe in a number of cell lines.","label":0}
{"pair_id":"AIMed.d74.s627.p0","sentence":"Two cDNA clones encoding a receptor for human ps granulocyte-macrophage colony-stimulating factor pe (ps hGM-CSF-R pe) were isolated by expression screening of a library made from human placental mRNA.","label":1}
{"pair_id":"AIMed.d165.s1389.p0","sentence":"We have exploited the availability of the cloned ps XPB pe, ps XPD pe, p62, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p1","sentence":"We have exploited the availability of the cloned ps XPB pe, XPD, ps p62 pe, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p2","sentence":"We have exploited the availability of the cloned ps XPB pe, XPD, p62, ps p44 pe, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p3","sentence":"We have exploited the availability of the cloned ps XPB pe, XPD, p62, p44, and ps p34 pe genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p4","sentence":"We have exploited the availability of the cloned ps XPB pe, XPD, p62, p44, and p34 genes (all of which encode polypeptide subunits of ps TFIIH pe) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p5","sentence":"We have exploited the availability of the cloned XPB, ps XPD pe, ps p62 pe, p44, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p6","sentence":"We have exploited the availability of the cloned XPB, ps XPD pe, p62, ps p44 pe, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p7","sentence":"We have exploited the availability of the cloned XPB, ps XPD pe, p62, p44, and ps p34 pe genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p8","sentence":"We have exploited the availability of the cloned XPB, ps XPD pe, p62, p44, and p34 genes (all of which encode polypeptide subunits of ps TFIIH pe) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p9","sentence":"We have exploited the availability of the cloned XPB, XPD, ps p62 pe, ps p44 pe, and p34 genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p10","sentence":"We have exploited the availability of the cloned XPB, XPD, ps p62 pe, p44, and ps p34 pe genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p11","sentence":"We have exploited the availability of the cloned XPB, XPD, ps p62 pe, p44, and p34 genes (all of which encode polypeptide subunits of ps TFIIH pe) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p12","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, ps p44 pe, and ps p34 pe genes (all of which encode polypeptide subunits of TFIIH) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p13","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, ps p44 pe, and p34 genes (all of which encode polypeptide subunits of ps TFIIH pe) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"AIMed.d165.s1389.p14","sentence":"We have exploited the availability of the cloned XPB, XPD, p62, p44, and ps p34 pe genes (all of which encode polypeptide subunits of ps TFIIH pe) to examine interactions between in vitro-translated polypeptides by co-immunoprecipitation.","label":0}
{"pair_id":"BioInfer.d260.s0.p0","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of three polypeptides encoded by the UL5, ps UL8 pe, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p1","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of three polypeptides encoded by the ps UL5 pe, UL8, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p2","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a ps helicase-primase pe that consists of three polypeptides encoded by the UL5, UL8, and ps UL52 pe genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":1}
{"pair_id":"BioInfer.d260.s0.p3","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the ps UL5 pe, ps UL8 pe, and UL52 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d260.s0.p4","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the UL5, ps UL8 pe, and ps UL52 pe genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d260.s0.p5","sentence":"Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of three polypeptides encoded by the ps UL5 pe, UL8, and ps UL52 pe genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.","label":0}
{"pair_id":"BioInfer.d348.s2.p0","sentence":"These results suggest that the subcellular distribution of ps cofilin pe as well as its interaction with ps actin pe in vivo is regulated by its phosphorylation and dephosphorylation.","label":1}
{"pair_id":"AIMed.d76.s643.p0","sentence":"Further, anti-ps CD5 pe and anti-ps p56lck pe coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.","label":0}
{"pair_id":"AIMed.d161.s1358.p0","sentence":"We have localized the region of interaction to tyrosine 580 in the carboxyl end of ps SHPTP2 pe and to the SH2 domain in the carboxy-terminus of ps Grb7 pe.","label":0}
{"pair_id":"BioInfer.d734.s0.p0","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of ps integrin pe receptors, actin and cytoskeletal proteins such as vinculin and ps talin pe.","label":0}
{"pair_id":"BioInfer.d734.s0.p1","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of ps integrin pe receptors, actin and cytoskeletal proteins such as ps vinculin pe and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p2","sentence":"They had altered adhesive properties as measured by their ability to bind to a ps fibronectin pe-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of ps integrin pe receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p3","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a ps rac-1 GAP pe alters the assembly of ps integrin pe receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":1}
{"pair_id":"BioInfer.d734.s0.p4","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of ps integrin pe receptors, ps actin pe and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p5","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as ps vinculin pe and ps talin pe.","label":0}
{"pair_id":"BioInfer.d734.s0.p6","sentence":"They had altered adhesive properties as measured by their ability to bind to a ps fibronectin pe-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and ps talin pe.","label":0}
{"pair_id":"BioInfer.d734.s0.p7","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a ps rac-1 GAP pe alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and ps talin pe.","label":1}
{"pair_id":"BioInfer.d734.s0.p8","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, ps actin pe and cytoskeletal proteins such as vinculin and ps talin pe.","label":0}
{"pair_id":"BioInfer.d734.s0.p9","sentence":"They had altered adhesive properties as measured by their ability to bind to a ps fibronectin pe-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as ps vinculin pe and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p10","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a ps rac-1 GAP pe alters the assembly of integrin receptors, actin and cytoskeletal proteins such as ps vinculin pe and talin.","label":1}
{"pair_id":"BioInfer.d734.s0.p11","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, ps actin pe and cytoskeletal proteins such as ps vinculin pe and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p12","sentence":"They had altered adhesive properties as measured by their ability to bind to a ps fibronectin pe-coated glass surface, suggesting that the expression of a ps rac-1 GAP pe alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p13","sentence":"They had altered adhesive properties as measured by their ability to bind to a ps fibronectin pe-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, ps actin pe and cytoskeletal proteins such as vinculin and talin.","label":0}
{"pair_id":"BioInfer.d734.s0.p14","sentence":"They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a ps rac-1 GAP pe alters the assembly of integrin receptors, ps actin pe and cytoskeletal proteins such as vinculin and talin.","label":1}
{"pair_id":"BioInfer.d616.s0.p0","sentence":"The genes considered are those for ps 5S pe, ps 5.8S pe and 18S ps rRNA peps rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p1","sentence":"The genes considered are those for 5S, ps 5.8S pe and ps 18S rRNA peps rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p2","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, ps profilins Ia pe\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p3","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p4","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, ps actin I pe, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p5","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, ps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p6","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p7","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, ps profilins I pea\/ps p pe and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p8","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p9","sentence":"The genes considered are those for 5S, ps 5.8S pe and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p10","sentence":"The genes considered are those for ps 5S pe, 5.8S and ps 18S rRNA peps rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p11","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, ps profilins Ia pe\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p12","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p13","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, ps actin I pe, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p14","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, ps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p15","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p16","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, ps profilins I pea\/ps p pe and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p17","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p18","sentence":"The genes considered are those for ps 5S pe, 5.8S and 18S ps rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p19","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, ps profilins Ia pe\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p20","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p21","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, ps actin I pe, profilins Ia\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p22","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, ps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p23","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, profilins Ia\/p and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p24","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, ps profilins I pea\/ps p pe and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p25","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, profilins Ia\/p and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p26","sentence":"The genes considered are those for 5S, 5.8S and ps 18S rRNA pe, actin I, profilins Ia\/p and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p27","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia pe\/p and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p28","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, ps profilins Ia pe\/p and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p29","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia peps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p30","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia pe\/p and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p31","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia peps profilins I pea\/ps p pe and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p32","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia pe\/p and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p33","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins Ia pe\/p and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p34","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, profilins Ia\/p and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p35","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins pe Ia\/p and ps pr pe, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p36","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins peps myosins pe IB, ps my pe and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p37","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins I pea\/ps p pe and pr, ps myosins pe IB, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p38","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins peps myosins IB pe, ps my pe and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p39","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins pe IB, ps my pe and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p40","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, ps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p41","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, profilins Ia\/p and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p42","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, ps profilins I pea\/ps p pe and pr, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p43","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, profilins Ia\/p and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p44","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, ps actin I pe, profilins Ia\/p and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p45","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins pe Ia\/p and ps pr pe, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p46","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins peps profilins I pea\/ps p pe and ps pr pe, myosins IB, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p47","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins pe Ia\/p and ps pr pe, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p48","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins pe Ia\/p and ps pr pe, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p49","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins I pea\/ps p pe and pr, ps myosins pe IB, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p50","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins peps myosins IB pe, my and ps my pe, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p51","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins pe IB, my and ps my pe, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p52","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins I pea\/ps p pe and pr, ps myosins IB pe, my and my, and calmodulin.","label":0}
{"pair_id":"BioInfer.d616.s0.p53","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, ps profilins I pea\/ps p pe and pr, myosins IB, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"BioInfer.d616.s0.p54","sentence":"The genes considered are those for 5S, 5.8S and 18S rRNA, actin I, profilins Ia\/p and pr, ps myosins IB pe, my and my, and ps calmodulin pe.","label":0}
{"pair_id":"AIMed.d47.s411.p0","sentence":"Crystal structure of the ps BMP-2 pe-ps BRIA pe ectodomain complex.","label":1}